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Low dose intravenous (I.V.) and subcutaneous (sc) erythropoietin
(EPO) in end-stage renal failure. L.P. McMahon, J.K. Dawborn, Renal
Unit, Department of Medicine, Austin Hospital, Heidelberg, 3084,
Victoria, Australia. Twelve stable hemodialysis patients were given
recombinant human EPO (rHuEPO) over 14 weeks. Two groups (A and
B) were matched for age, sex, weight, Hb (<8 g/dl or transfusion
dependent), duration of dialysis and prior transplantation. No patient
was iron deficient. Group A was given 25 U/kg 3 times per week i.v.,
and Group B 25 U/kg twice per week s.c. At the end of 7 weeks doses
were doubled. Serum EPO levels were measured after the first injec-
tion. Peak levels of 450 25 and 53 6 mU/mI occurred 30 minutes and
20 hours post iv. and s.c. injection, respectively. Response to s.c.
administration was comparable to i.v. at both 7 (P = 0.4) and 14 (P =
0.6) weeks despite a 33% lower weekly dosage. Rise in Hb was 2.8
0.5 (i.v.) and 2.5 0.6 (s.c.) g/dl. A strong correlation was observed
between response to rHuEPO and initial ferritin levels (r = 0.62, P =
0.004). A poor early response was observed in patients (N = 5) with
initial ferritin levels less than 500 imol/liter. Three patients had an
inadequate response (<2.5 gldl rise in Hb). In one this was due to a
prolonged pneumonic illness. Two others (s.c.) did not respond to iron
transfusion, for which no cause could be found. They subsequently
responded to higher doses of rHuEPO (175 U/kg twice per week). Two
patients required an increase in antihypertensive mediation and there
was one A-V fistula thrombosis. There were no other side effects. In
most cases a good response to rHuEPO can be obtained with low
dosages and with few side effects. Subcutaneous therapy is at least as
effective as i.v. Adequate iron stores appear essential for an optimal
response.
Prevention of preeclampsia in women with renal disease. R.A. North,
K.F. Fairley, M. Kloss, B. Jhle, P. Kincaid-Smith, Royal Women's
Hospital, Carlton, Victoria 3053, Royal Melbourne Hospital, Victoria
3050, Australia. In a randomized controlled trial using prophylactic
subcutaneous heparin (15,000 plday) and dipyridamole (300 mg/day)
in patients with renal disease, 20/21 entered had previous severe early
preeclampsia, 13 had previous fetal losses. 5/11 controls developed
hypertension compared to 0/9 treated (P < 0.05) and proteinuria
occurred in 6/11 controls and 0/9 treated (P < 0.05), 2 neonatal deaths
occurred in controls. Twenty-two percent of the treated and 73% of the
control women developed complications (P < 0.01). In a prospective
nonrandomized study prophylactic heparin and dipyridamole were used
in a further 48 pregnancies in 45 women with renal disease at high risk
of preeclampsia. Results in the index pregnancy were compared with
previous pregnancies. In 40 multiparous women, 74% of previous
pregnancies were complicated by preeclampsia and 69% had associated
perinatal losses. In the treated pregnancies, proteinuric hypertension
occurred in 15% (P < 0.001 compared to past history) and one perinatal
loss occurred in a woman with lupus inhibitor. In addition a controlled
non-randomized trial was conducted. The treatment group (N = 27) was
compared to matched controls (N = 34) who had no therapy. Both
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groups were comprised of patients managed during the same period
with underlying renal disease or hypertension and a past history of early
severe or recurrent preeclampsia with fetal losses. Fifteen percent of
the treated pregnancies were complicated by proteinuric hypertension
compared to 50% of the controls (P < 0.01). One perinatal loss occurred
in the treated group secondary to cervical incompetence, whereas there
were 7 losses in the control group, all associated with early onset
preeclampsia (P = 0.055). Prophylactic heparin and dipyridamole
prevents preeclampsia and perinatal loss in high risk women with renal
disease.
Reducing the false negative rate of radionuclide scans in renal artery
stenosis (RAS): The value of captopril. KM. Bannister, R. Gaffney, D.J.
Torpy, Renal Unit and Department of Nuclear Medicine, Royal Ade-
laide Hospital, Adelaide 5000, Australia. Quantitative mTc DTPA
renography has been suggested as a useful non-invasive screening test
for functionally significant RAS. However, the false negative rate of
this test is not clear as such cases may not proceed to angiography.
Recent studies report an increased yield of true positives after captopril
enhancement of the renal scan. We compared the positive predictive
value of quantitative 99mTc DTPA renal scans before and 60 minutes
after an oral 25 mg dose of captopril in 13 patients evaluated by renal
arteriography, including renal vein renin sampling in 6 cases. Three
quantitative parameters were assessed: differential renal function,
cortical transit time ofmTc DTPA and aortic/kidney slope ratio (initial
perfusion). Mean and 95% confidence limits for these values were
established in 15 controls with essential hypertension. A change of
>20% in the ratio of 10 minute renal cortical Counts after captopril
indicated a positive effect from ACE inhibition. Global GFR was
measured using a one shot, 2 plasma sample technique. Ten of 13
angiographically evaluated cases had >90% RAS (1/10 bilateral). The
captopril enhanced scans correctly identified 9 of these, including 6/6
cases in which renal vein renin sampling showed a differential ratio of
>1.5. All of 5 patients in which global GFR was measured showed a
significant fall (>20 mI/mm) post-captopril. In contrast, although 5 of
the patients had slightly smaller kidneys on the side of the RAS, only
2/10 fulfilled at least 2 of the defined quantitative criteria for RAS on the
pre-captopril scan. Both pre- and post-captopril scans were normal in 3
cases of <50% stenosis. We conclude that captopril enhanced renal
scans improve the positive predictive value in the diagnosis of func-
tionally significant RAS, and recommend their use as a screening test.
DMSA scintigraphy in children at the time of acute urinary tract
infection (UTI)—A prospective study. A.R. Rosenberg, M.P. Brydon,
M.A. Rossleigh, D. Leighton, S. Bass, M. Gibbe son, T. McDonald, B.
Elison, R.H. Farnsworth, Departments of Nephrology, Nuclear Med-
icine, Radiology and Urology, The Prince of Wales Children's Hospital
NSW 2031, Australia. DMSA scanning is now accepted as the most
sensitive tool for the detection of chronic renal scarring in children with
a history of UTI and vesicoureteric refiux (VUR). There have been
isolated reports of DMSA abnormalities in children at the time of acute
UTI; we report interim results from the first prospective study to
examine the incidence of such abnormalities, their natural history and
whether they correlate with the presence of VUR. Sixty-six previously
well children with acute UTI had DMSA scans performed within 72
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hours of presentation; 40 kidneys in 33 children were abnormal.
Twenty-seven kidneys have so far been rescanned at 3 to 6 months; the
abnormal appearances have remained unaltered in 4, improved in 12
and become normal in 11. Ten kidneys have been rescanned at 12
months; of the S previously improving scans 3 have now become normal
and the other 2 continue to show improving uptake, while those 2
kidneys that were previously unchanged remain so. Fourteen of 47
children who had micturating cystourethrography were found to have
significant VUR (grades 2—5); of these 14, 12 had abnormal DMSA
scans and the remaining 2 had dilated upper tracts on ultrasound
examination. The following provisional conclusions can be drawn: I.)
The incidence of DMSA abnormalities at the time of acute UTI is
surprisingly high (50%) 2.) There is a tendency for these abnormalities
to resolve with time. It follows that DMSA scans performed in the first
few months after UTI have to be interpreted with caution. 3.) An
abnormal DMSA scan at the time of UTI identifies most children with
significant VUR and it would appear that a combination of ultrasound
and DMSA scan identifies them all. These results may have major
implications for the clinical investigation of children with UTI.
Dialysis and transplantation in the Aboriginal population of South
Australia and the Northern Territory 1971—1988. D.J. Pugsley, A.P.S.
Disney, G.R. Russ, TN. Mathew, Renal Unit Queen Elizabeth Hospi-
tal, Woodville, South Australia 5011. Between 1971 and 1988 70
Aborigines with end-stage renal failure (ESRF) have entered dialysis
programs in SA and the NT. Sixty-five per cent entered between 1985
and 1988. The modal age at entry was 30 to 50 years and 55% of the
patients were female. Thirty patients (43%) presented for the first time
with established ESRF. In 1987, the population rate for entry on to
dialysis programmed in SA/NT was 53 per million, whereas for Aborig-
ines, the rate was 375 per million. Thirty-seven Aborigines underwent
renal transplantation between 1972 and 1988; two thirds of these
transplants were performed between 1984 and 88. The integrated
survival for all Aboriginal patients following dialysis and transplanta-
tion (89% at 12 months and 68% at 3 years) was not significantly
different from the overall 1964 to 1988 experience of white Australian
patient in SA/NT, but the survival of Aborigines entering the program
between 1983 and 1988 was significantly worse than a comparable group
of Australians, matched on age. The patient and graft survival of
Aborigines undergoing a first renal transplant between 1983 and 1988
was not significantly different from that of a comparable white Austra-
lian group. Thirteen Aborigines have received transplants from living
relatives (10 of the last 20 transplants). The success of this program in
terms of patient and graft survival conceals a multiplicity of social,
geographical and treatment problems inherent in the medical manage-
ment of the Aboriginal population.
Preliminary findings from a study of renal disease in Australian
Aborigines. P.G. Van Buynder, D.J. Pugsley, J.D. Mathews. Menzies
School of Health Research, Darwin, N. T. 0810, Australia. To help
explain the high prevalence of chronic renal disease we studied the
presence of renal disease markers and potential risk factors in three
Aboriginal communities in the Northern Territory. In the desert com-
munity there was a high rate of renal disease (in those aged 35 or more
23% had a protein excretion >500 mg/liter), a high rate of diabetes (27%
with 2 HR glucose >11 mmol/liter) and a high rate of being overweight
(BMI >25 in 65%). In this community 64% of those with renal disease
had diabetes, and in turn over half of diabetics had proteinuria. In the
desert community there was a high rate of urinary infection (15% pure
culture rate), again mainly in the diabetics. The two coastal communi-
ties differed in protein excretion in adults (50% and 10% >500 mg/liter).
There was less diabetes (14% and 11%) and less were overweight (36%
and 20%). In the first coastal community there was only a 4% abnor-
mality rate on imaging. Thus it appears that in the desert community
renal disease was most closely related to diabetes mellitus (and infec-
tion), whereas in at least one of the coastal communities it appeared to
be more closely related to chronic glomerulonephritis. Over all com-
munities the serum creatinine level was raised (>120 mmol/liter) in
8.9% of persons aged 35 or more. These preliminary data confirm that
the rate of renal disease is high in Aboriginal Australians, but suggest
that the problem is of heterogeneous origin.
Comparative response to recombinant human erythropoietin
(rHuEPO) at different levels of hemoglobin. L.P. McMahon, M. Austin,
J.K. Dawborn, Renal Unit, Department of Medicine, and Department
of Nuclear Medicine, Austin Hospital, Heidelberg, 3084 Victoria,
Australia. Twelve stable hemodialysis patients were divided into two
groups (A and B) and matched for age, sex, weight, Hb (6.3 0.5, 6.4
0.9 g/dl, SE), duration of dialysis and prior transplantation.
rHuEPO was given to achieve and then maintain Hb at either 9 0.5
(A) or 12 0.5 (B). Patients were unaware of their Hb, and were
assessed initially, on reaching target Hb, and at the end of 3 months
treatment. Seven patients (5 A; 2B) have completed the second assess-
ment, 3 (A) have completed the study. Subjective evaluation was
performed using a standardized questionnaire: sickness impact profile
(SIP), a behaviorally based measure of physical (P), psychosocial (PS)
and overall (T) dimensions of health. Objective evaluation (mTc
labeled radionuclide ventricolu-gram) examined cardiac output (CO)
and ejection fraction (EF) at rest, 3 mm exercise (bicycle ergometer),
and at end of exercise (exhaustion); work done (WD); resting pulse
(RP); and arterial lactate (AL, peak exercise). Initial parameters did not
differ significantly between groups. Reaching target Hb (A) produced an
improvement in all SIP scores (P:2.3 1.5 vs. 9.9 1.9, P = 0.01;
PS:6.2 2.2 vs. 16.9 6.3, P = 0.15, T: 5.6 0.9 vs. 17.8 3.6, P =
0.03) which was sustained or increased after 3 months treatment. Group
B was similar (N = 2). Four patients (A) who initially felt unfit for work
felt fit after reaching target Hb (P = 0.02). Objective parameters showed
similar changes. At target Hb (A, N = 4), CO after 3 mm exercise was
reduced (7.3 0.4 vs. 9.1 0.5, P = 0.10); this was also apparent after
maintaining Hb for 3 months (N = 2). EF did not change with
treatment. WD (668 266 vs. 404 158, watts, P = 0.08); PR (73 2
vs. 78 2, P = 0.06); and AL (5.1 1.4 vs. 6.5 1.5, mmol/liter, P =
0.03) all improved with treatment. Group B (N = 2) was again similar.
Modest increases in Hb with rHuEPO improve quality of life. This is
confirmed by significant subjective improvements and objective evi-
dence of better cardiac function in response to exercise and work
capacity.
Cost-effectiveness of weekly and fortnightly subcutaneous erythropoie-
tin (EPO) in renal failure. M.A.B. Thomas, K. North, C. Lim, H.
Moody, P.E. Hurst, G.N. Thatcher, B.M. Saker, Department of
Nephrology, Royal Perth Hospital, Perth WA 6000, Australia. The cost
of intravenous EPO in renal failure (approx. $A1O,000/patient/year)
limits its broader application. To maximize cost-efficient EPO use, a
pilot regimen of decreasing frequency subcutaneous (SC) administra-
tion was utilized. 7 home hemodialysis and CAPD patients were
commenced on one ampoule (4000 units) s.c. twice weekly, and the
dose interval increased to the maximum capable of maintaining hemo-
globin (Hb) concentration >90 glliter. All patients were symptomati-
cally anaemic (mean Hb = 62) and either transfusion (TF)-dependent
(median TF frequency = 1 units/S weeks), iron-loaded and anti-HLA
antibody sensitized (N = 6) or with religious objection to transfusion (N
= I). The initial dose was equivalent to 142 (97-190) units/kg/week. The
rate of rise of Hb following commencement was 3.3-5 g/liter/week.
During therapy, one patient developed hypertension responding to
antihypertensive therapy and fluid removal, and 2 patients had asymp-
tomatic exacerbations of pre-existing hyperkalemia. No patient com-
plained of injection site discomfort. After 5(2-9) months, the current
maintenance EPO dose is 4000 units once weekly in 6 patients [=
74(49-95) units/kg/week] and fortnightly in I patient [= 55 units/kgl
week]. At a cost of $A76/ampoule, the annual cost if $A3952 for weekly
and $A1976 for fortnightly EPO therapy. This pilot study has shown
weekly and fortnightly s.c. EPO therapy to be hematologically effective
and to generate considerable cost-savings.
Desferrioxamine (DFO) enhances the response to human recombinant
erythropoietin (rHuEPO). S.D. Roger, J.H. Stewart, D.C.H. Harris,
Department of Medicine, Westmead Hospital, Westmead, NSW 2145,
Australia. DFO has been shown to increase erythropoiesis in hemodi-
alysis patients with even mild aluminium excess. The present study
examined the effect of DFO on the response to rHuEPO (40 mg/kg!
dialysis IVI) in a random subset of 17 transfusion-dependent patients
receiving optimal hemodialysis treatment. Seven patients received
DFO (20-30 mg/kg/dialysis IVI and rHuEPO, and 10 rHuEPO alone.
There was no difference between the 2 groups in age, initial Hb, initial
plasma aluminium (5.3 vs. 3.3 j.mol/liter), aluminium after DFO chal-
lenge (10.5 vs. 8.5 moLfliter) and initial ferritin (121 vs. 315 pg/liter)
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but, by chance, dialysis time was longer in the DFO group (69 12 vs.
32 9 mo, P 0.02). Hb rose more quickly in the DFO group:
DFO +
rHuEPO
rHuEPO
alone P
Rise in Hb gluten 0.61 0.06 0.29 0.04 <0.001
day
Rise in Rb glliten/ 3.35 0.3 1.88 0.26 <0.001
100 U EPO/kg
However, adverse events were common in the DFO group, with
reversible visual toxicity in three. One patient died of a "Reyes-like
syndrome" while receiving DFO, but the cause was not determined. In
conclusion, although DFO enhances the response to rHuEPO in HD
patients, the combination is unsafe in the setting described.
A ten year retrospective analysis of renal biopsies from an Australian
provincial city. J. W. MacD. Agar, Geelong Hospital, Geelong, Victoria
3220, Australia. A retrospective analysis has been undertaken of 279
consecutive paediatric and adult renal biopsies performed between
January 1979 and August 1989 in an Australian provincial city with an
effective population base of 250,000. This series is unique as all biopsies
have been performed by a single nephrologist at a single hospital, thus
largely eliminating referral bias and differences in nephrological assess-
ment. This analysis therefore provides an accurate assessment of a
microcosm of glomerular disease in Australia. Forty-two variables
including age, sex, post-code, symptoms, laboratory data and histolog-
ical diagnosis were analyzed while follow-up data permitted outcome
prediction. Among the major diagnostic groups were 57 cases of IgA
nephropathy (21.2%), 25 membranous nephropathy (9.3%), 20 focal
glomerulosclerosis (7.5%) and 20 minimal lesion nephrotic syndrome
(7.5%), which permitted comparative analysis of clinical and laboratory
data. Analyses of regional geography and socio-economic factors
provided interesting insights into possible environmental etiological
factors. Post-code analysis yielded an incidence of all types of glomer-
ulonephritis between 1600 and 1800 cases per million population in
northern industrial suburbs compared with 900 to 1100 per million in
southern residential areas. This series provided a further addition to our
understanding of the incidence and distribution of glomerulonephritis in
a representative Australian city.
Predictive value of ureteric catheterization in the diagnosis of renal
infection: An experimental evaluation. T.E. Miller, J.P. Lecamwasam,
G. Findon, Department of Medicine, University of Auckland, Auck-
land, New Zealand. Ureteric catheterization has assumed a position as
the gold standard when studies are carried out to localize the site of
urinary tract infection. The belief is that analysis of ureteric urine will
disclose the bacteriologic and pathologic status of the kidney, but there
is a lack of data to support this assumption. Studies were therefore
carried out using experimentally-induced renal infection to determine
whether the bacteriologic and pathologic status of the kidney could be
predicted from the laboratory evaluation of ureteric urine. Uretenc
samples were collected at regular intervals up to 8 weeks after challenge
and quantitative bacteriologic and cytologic examinations carried out.
Animals were then sacrificed and the gross, bacteriologic and histo-
pathologic status of the kidneys determined and compared with the data
obtained from the ureteric catheterizations. Animals with experimen-
tally induced pyelonephnitis demonstrated a consistent level of renal
infection throughout the study, and showed gross and histopathologic
changes classically associated with acute and chronic pyelonephritis. In
acute pyelonephritis, the composition of the ureteric urine reflected the
pathologic status of the kidney, although in a few cases ureteric samples
were either sterile or cell free. Kidneys from animals with chronic
pyelonephritis were either persistently infected or sterile, and in most
cases, the ureteric urine from both groups was free of infection. Pyuria,
however, was demonstrable in both these situations. In subclinical
pyelonephritis, ureteric samples from infected kidneys were variably
culture positive, although pyuria was a common observation. The
results have provided experimental data which could be applied to
improve the predictive value of equivalent clinical analyses.
Sequential nephron blockade in the management of refractory edema.
M.J. Field, A. Kiyingi, C. Pawsey, J. Yiannikas, J.R, Lawrence, W.
Arter, Departments of Medicine, University of Sydney, and Cardiol-
ogy, Concord Hospital, NSW2139, Australia. We developed a protocol
based on physiological principles for the treatment of patients with
severe edema due to advanced heart failure (CCF). All patients studied
were refractory to maximal conventional therapy, including a loop
diuretic, used both orally (frusemide >200 mg/day or equivalent) and
intravenously, digoxin (where appropriate), and ACE inhibition with
captopril or enalapril. A potassium-sparing diuretic was included in the
therapy of all patients, except where it was not tolerated due to
hyperkalemia. On entry into the study, step 1 was the addition of
metolazone (a quinazoline sulfonamide diuretic acting chiefly at the
early distal tubule), 1.25 to 10 mg/day, to the existing therapy. If the
response (increased diuresis accompanied by loss of weight) was
inadequate, metolazone was discontinued and a 72 hr i.v. infusion of
dobutamine (5 to 15 sg/kg/min) was given. If this failed, metolazone
was reintroduced. Seventeen patients, aged 56 to 83 years, with NYHA
Class IV CCF were studied. All patients were disabled by fluid
retention and had an intolerably poor quality of life despite maximal
conventional treatment. Mean left ventricular ejection fraction was 21.2
1.5% (sEM). Twelve responded satisfactorily to initial addition of
metolazone (mean weight loss W 8.3 kg). Of the 5 who required
dobutamine, 2 responded promptly (W 4.4 kg), and of the other 3, two
benefited from further metolazone. Thus 16 patients improved, 12 to
NYHA Class II and 4 to Class III. Metolazone caused transient
hypokalemia in 7 patients and severe hyponatremia and renal impair-
ment in one. Fifteen patients were discharged home well, while 2 died
in hospital, both from acute myocardial infarction. We conclude that
the addition of metolazone to conventional diuretic regimes, with or
without 'priming' with dobutamine, may promote diuresis in refractory
edema, presumably by blocking compensatory Na reasborption in the
'early distal' segment of the nephron.
Acute pyelonephritis (PN): A review of the clinical features and imaging
modalities in 84 patients. I. Fraser, P. Kincaid-Smith, J.A. Whitworth,
M. Lichtenstein, B. Tress, D. Birch, Royal Melbourne Hospital,
Victoria 3050, Australia. Eighty-four sequential patients (75 female, 9
male) presenting to the Royal Melbourne Hospital with clinical PN
(fever, loin pain, pyuria or bacteriunia) were randomized to either
Imipenem-Cilastin, Aztreonam, Ceftibuten, or Amoxycillin and Genta-
micin. Two patients were pregnant and 23 had abnormalities on
intravenous pyelography (21 female, 3 male); reflux nephnopathy (5),
renal calculi (5), duplex ulcers (4), analgesic nephnopathy (2), pelvo-
ureteric junction obstruction (2), horseshoe kidney (1), partial nephnec-
tomy (I), medullary sponge kidney (I), polycystic kidneys (I) and a
ureterocele (1). Of the 68 patients with normal nephrograms, 23 (34%)
had an abnormality on either dimercaptosuccinic acid scintography
(DMSA) (13), computerized axial tomography (CAT) (7) or both (3) at
the time of their acute infection. These include wedge-shaped defects of
one or more poles on DMSA, areas of reduced attenuation of CAT
scan. Repeat DMSA in 8 patients at 6 months to 1 year revealed cortical
scarring in 4. Those treated with either Imipenem-Cilastin on Aztreo-
nam were afebnile at day 2.6 (mean) compared to day 3.5 (mean) for
Amoxycillin and Gentamicin.
A comparison of Captopril and Enalapril in the management of
hypertension secondary to renal disease. 1. Macdonald, P. Champion de
Crespigny, T. Hewitson, P. Kincaid-Smith, Department of Nephrology,
Royal Melbourne Hospital, Victoria 3050, Australia, Deterioration in
renal function has been reported in patients with renal disease treated
with converting enzyme inhibitors (CEL). CEI have reduced proteinuna
and improved renal function in animal models. We compared the
efficacy of Captopril and Enalapril, in patients with hypertension
secondary to biopsy proven renal disease with random allocation to
Captopril (N = 35) and Enalapril (N = 34). Two weeks pre-treatment
was followed by 24 weeks of treatment. Blood pressure (BP) was
measured each 2 weeks for 2 months, and monthly from week 8 to 24.
Serum creatinine (Sr), creatinine clearance (Ccr) blood urea (BU) and
24-hour urinary protein excretion (Up) were measured monthly. Mean
dose of Captopril and Enalapnl at weeks 2, 12 and 24 was 24, 81, 136
and 9, 19, 26 mg/day, respectively. Supine and standing systolic BP and
diastolic BP in both groups was reduced significantly by treatment week
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2 (P < 0.05) and week 24 (P < 0.001). There were no significant
differences in BU, S. or Ccr after 24 weeks of treatment in either
group. There was a significant change in Up,. excretion at week 24 with
proteinuria reduced by both Captopril (P < 0.05) and Enalapril (P <
0.005). Captopril and Enalapril reduce the blood pressure in biopsy-
proven renal disease and reduce proteinuria without alteration in renal
function.
Uterine artery wave forms in pregnancy in patient with renal disease.
P. Kincaid-Smith, A. Ngu, R.A. North, M. Kloss, K.F. Fairley, Royal
Melbourne Hospital, Victoria 3050, Royal Women's Hospital, Carlton
3053, Australia. Uterine artery wave forms have been reported as a
method of predicting preeclampsia. Uterine artery wave form has been
studied in 24 patients with biopsy-proven renal disease. Studies were
conducted between 18 and 36 weeks of gestation and serial studies were
available in 19 patients. The diastolic/systolic ratio resistance index and
pulsability index were calculated in all cases. Nine patients had
abnormal values for 2 or more parameters. All had active or advanced
renal disease of a type in which the pregnancy outcome is usually poor.
(3 advanced FGS with impaired function, 2 active IgA GN with
crescents, I lupus nephritis with circulating anticoagulant, I active
membranous GN, I advanced diabetic GS, I MCGN). Seven of the 9
patients with the most abnormal wave forms were treated with heparin
and dipyridamole or plasma exchange. Treatment resulted in prompt
improvement of wave form parameters in patients with serial studies.
Neonatal deaths (NND) (2) or fetal deaths in utero (FDIU) (2) occurred
in 4 of the 24 pregnancies. With the exception of 1 patient with a
circulating lupus anticoagulant, no fetal loss occurred in patients treated
with heparin and dipyridamole. Two NNDs and one FDIU occurred in
patients allocated to "no treatment" in a heparin-dipyridamole con-
trolled trial. Uterine artery wave forms may be useful in predicting the
outcome of pregnancy in patients with renal disease and in monitoring
the effect of treatment.
Clinical studies in acute pyelonephritis. D. Birch, S. John, 1. Fraser,
K.F. Fairley, P. Kincaid-Smith, Department of Nephrology, Royal
Melbourne Hospital, Victoria 3050, Australia. The characteristics of
the infecting bacteria were studied in 84 patients with acute pyelone-
phritis. Samples of urine (67 CSU, 17 MSU) and venous blood were
cultured for conventional urinary pathogens and fastidious species.
Sixty-nine of 84 (82%) patients were culture-positive (>50 CFU/ml).
Fifty-seven of these harbored E. coli and 9 yielded other conventional
pathogens. Four patients harbored fastidious species. Colony counts of
E. coli were in the range 102 > io CFU/ml. Counts of fastidious
bacteria were in the range l04106 CFU/ml. Sixty-five of 69 culture
positive patients had pyuna (>2000 cells/mi) as did 10/15 culture-
negative patients. Six patients had bacteremia (SE. coli, 1 P. mirabilis).
Type 1 pili were detected on 12/5 1 E. coli in the urine sediment and on
21/57 isolated from agar media. P. pili were present on 28/51 E. coli in
the urine and on 38/57 isolates. One of 6 E. coli from blood cultures
carried type I pili and 4/6 carried P pili. P pill were present more
frequently than type 1 pili (P < 0.01). In 9 E. co/i culture isolates,
expression on type I pili was more marked on human blood agar than on
horse blood agar. Patients with acute pyelonephritis may harbor a wide
range of conventional and fastidious bacteria in the bladder.
Improved growth velocity in children with end-stage renal failure
following treatment with human growth hormone. D.J. Lewis, M.
Mclver, N.M. Thomson, Victorian Paediatric Dialysis & Transplanta-
tion Unit, Monash Medical Centre, Clayton, Victoria, Australia. A
most serious consequence of end-stage renal failure (ESRF) in child-
hood is extreme growth retardation (GR), despite improved nutrition
and management of renal osteodystrophy. Since the introduction of
human growth hormone (hGH) improvement in the growth velocity of
these children has been reported overseas despite the fact that endog-
enous growth hormone concentrations are normal. The recent changes
in the guidelines for availability of hGH in Australia have allowed us to
treat 3 children with hGH. Their ages ranged from 8 to 16 years with
initial heights at least I standard deviation below the 3rd centile, growth
velocity below the 25th centile and bone ages 3 to 6 years below
chronological age. The duration of therapy has been 7 to 12 months.
The underlying renal diseases were focal segmental glomerulosclerosis,
cystinosis and renal dysplasia. Two patients were on continuous cycling
peritoneal dialysis and the third had chronic rejection. Further trans-
plantation was considered unlikely. All patients were prepubertal and
euthyroid at the commencement of hGH. Both children on dialysis have
been receiving erythropoietin (EPO) subcutaneously. The dosage of
hGH was determined by the Growth Hormone Committee and ranged
from 0.5 to I U/kg. Each child demonstrated an increase in growth
velocity to above the 90th centile, but as yet none has reached the 3rd
centile for height. There was a major improvement in appetite and in the
psychosocial problems related to short stature. The optimal manage-
ment of these children would be treatment with hGH prior to the onset
of severeCRF so that an acceptable adult height could be obtained.
Demonstration of hepatic involvement in infantile polycystic kidney
disease with DISIDA scan. K. Waters, R. Howman-Giles, A. Lam, L.P.
Roy, J.F. Knight, Department of Nephrology, The Children's Hospital,
Camperdown, NSW 2050, Australia. Autosomal recessive polycystic
kidney disease (APCKD) is associated with hepatic fibrosis. Caroli's
disease is also associated with hepatic fibrosis and has been occasion-
ally reported in patients with APCKD. The nosology of the three
conditions is controversial. We have used non-invasive imaging tech-
niques to evaluate the extent of liver disease in our patients with
APCKD. All eight children attending our department who had been
identified as having APCKD by conventional criteria (family history,
physical examination and radiographic appearance) were submitted to
hepatic ultrasound and DISIDA scanning. Blood was drawn at the same
time for estimation of liver enzymes and bile salts. Six children (75%)
had abnormal hepatic ultrasounds: each showed increased echogenicity
consistent with hepatic fibrosis. Four of those size also showed bile
duct dilatation on ultrasound. The same six children had abnormal
DISIDA scans: 5 had dilated intrahepatic bile ducts and four of these
had tertiary dilatation of sufficient severity to be called Caroli's disease.
The sixth abnormal DISIDA scan showed cirrhosis and a non-function-
ing gall bladder. Serum liver enzymes and bile acids were normal in all
patients. This study demonstrates that hepatic fibrosis and bile duct
dilatation are both seen commonly in APCKD. Fifty percent of our
APCKD patients also fulfilled the diagnostic criteria for Caroli's dis-
ease. These disorders may be variable manifestations of a single
autosomal recessive condition.
Netilmicin versus fJ-lactam antibiotics for the treatment of patients with
severe or complicated urinary tract infections. R.R. Bailey, K.L. Lynn,
B.A. Peddie, R.A. Robson, Department of Nephrology, Christchurch
Hospital, Christchurch, New Zealand. The major groups of drugs that
have challenged the amino-glycosides as regards efficacy for the treat-
ment of severe gram-negative sepsis are the /3-lactam antibiotics and the
4-quinolones. Netilmicin is a semi-synthetic amino-glycoside which in
both experimental animal models and man has been shown to be
associated with a low incidence of nephrotoxicity and ototoxicity. We
have undertaken three prospective, randomized trials to compare the
efficacy and safety of netilmicin versus three /3-lactam antibiotics—
cefoperazone (1-2 g q12 hr), ceftriazone (2 g q24 hr) and aztreonam (1 g
q12 hr)—for the treatment of patients hospitalized with severe or
complicated UTIs. All patients were treated for 5 days. The results are
shown in the Table.
Netilmicin
Study No. Cured 13-lactam No. Cured
1
2
3
16
24
22
15
23
20
Cefoperazone
Ceftriaxone
Aztreonam
16
23
22
9
21
16
a = 0.037
No serious side effects or toxicity were noted. Five patients developed
diarrhea after treatment with cefoperazone and 6 after ceftriaxone. Six
patients treated with aztreonam had a minor, reversible disturbance of
liver function tests. Four patients (6.5%) developed a mild, reversible
disturbance of renal function after netilmicin. In summary all drugs
were effective for the treatment of patients with serious UTIs, and with
minimal toxicity.
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Wegener's granulomatosis with renal involvement: A 14-year experi-
ence. P.C.B. Sizeland, R.R. Bailey, K.L. Lynn, R.A. Robson, Depart-
ment of Nephrology, Christchurch Hospital, Christchurch, New
Zealand. Between 1974 and 1984 we have treated 17 patients (9 men)
with Wegener's granulomatosis involving the kidney (age 30-70 yr;
mean 55.5). Other systems involved included ENT 88% and lung 82%.
Two patients had bilateral hilar lymphadenopathy; in 1 this preceded
the diagnosis by several years. Renal biopsy showed a necrotizing
glomerulonephritis in all patients and in 15 there was crescent formation
(>50% in 6). Histological evidence of medium vessel vasculitis or
granuloma formation was found in only one biopsy. Initial treatment
included prednisone in all patients, cyclophosphamide in 14 and aza-
thiprine in 3. Treatment reversed acute renal failure in 4 of the 7 patients
with a plasma creatinine >0.50 mmol/liter. The hilar lymphadenopathy
resolved in both patients. Complications occurred in 9 patients and
included hemorrhagic cystitis (2), localized Herpes zosler(l), localized
Herpes simplex (3), disseminated Herpes simplex (I), and disseminated
adeno-carcinoma (I) and squamous cell carcinoma of the skin (1).
Seven patients have died: 5 from the disease or its treatment and 2 from
other causes. Three deaths occurring in the first year of follow-up were
due to renal failure or its therapy. Patient survival was 81% at 1 year
and 73% at 5 years. Of the 10 patients who were still alive and in full
remission 8 remained on treatment and 2 had been off treatment for over
2 years.
HTLV-1 Antibody In western Australian Aboriginals with renal failure.
H. Moody, M.A.B. Thomas, K. Christiansen, M. Bucens, Departments
of Nephrology and Microbiology, Royal Perth Hospital, State Health
Laboratory, Perth, Australia. HTLV-1 infection has been associated
with T cell malignancy and neurological disorders. Prevalence of this
virus is increased in certain Japanese and Jamaican populations.
Recently a 20% sero-prevalence has been reported in an Australian
Aboriginal population. End-stage renal failure in Aboriginals is prefer-
entially managed by living-related transplantation in this renal unit.
Transmission of HTLV-l by blood transfusion, sexually and from
mother to fetus is recognized, however, transmission by solid organ
transplant is unknown. The effect of immunosuppression on the clinical
course of HTLV-l infection is also unknown. To determine the preva-
lence of HTLV-l infection in Aboriginals with renal failure, sera from
19 Aboriginals referred with renal failure since 1987 were assessed for
the presence of IgG antibody to HTLV-l by immuno-fluorescent
antibody assay (sensitivity >97%, specificity = 100%), and were
compared with 10 first-degree relatives, 15 age-, sex- and location-
matched Caucasians without renal disease and 23 Caucasian, incenter
dialysis patients. Serum from one first-degree relative of an Aboriginal
patient with renal failure was positive. All other sera were negative.
This pilot study has demonstrated HTLV-l antibody in a potential
living-related renal donor. Transplantation did not proceed in this case
because the subject was diabetic. These results illustrate the potential
for transmission of HTLV-l by transplantation and support the need for
screening for HTLV-1 antibody until the clinical implications have been
defined.
Recombinant growth hormone added to dietary management of chil-
dren with chronic renal failure (CRF). K.F. Jureidini, M.J. van Renen,
R.J. Hogg, P.H. Henning, J.L. Penfold, Renal Unit and Department of
Paediatrics, Adelaide Children's Hospital, SA 5006, Australia. Ten
children aged between 3 and 15 years on strict dietary management of
CRF had recombinant growth hormone (Genotropin-Kabi) added to
their therapy. These children have previously been studied on a strict
low protein low phosphate diet, supplemented with keto acids, and
closely monitored. Compared with conventional dietary management
they had shown significantly improved growth and well-being, parathy-
roid hormone (PTH), calcium, phosphate and urea:creatinine ratio.
Their GFR had not fallen as rapidly as expected. Criteria for adding
Genotropin were CRF with GFR of <60 mi/min/! .73 m2, stage 2
puberty or less, height <3rd percentile and/or height velocity <50th
percentile for bone age, and to have been on the study diet for at least
a year. Thirty IU/m2/week of Genotropin is divided into 7 equal doses.
During the first six months there was no significant deterioration in
GFR, calcium, phosphate, PTH or urea:creatinine ratio. Height veloc-
ity was increased in all patients so that the mean growth in six months
was equal to the mean growth in the 12 months preceding the addition
of Genotropin. There was a significant associated rise in LGFI. There
have been no untoward side effects and the children have tolerated their
injections. Genotropin appears to be a safe and effective method of
increasing growth in children with CRF over and above dietary manip-
ulation alone.
Single dose quinolones compared with single dose trimethoprim for
treatment of bacterial cystitis. R.R. Bailey, B.A. Peddie, Department of
Nephrology, Christchurch Hospital, Christchurch, New Zealand. Sim-
ple urinary tract infections are often treated with large doses of
antimicrobial agents prescribed for longer than necessary. There is no
convincing evidence that a long course is more effective than a single
dose. Our previous studies have shown the most effective single dose
regimens for treating uncomplicated bacterial cystitis are trimethoprim
600 mg, co-trimoxazole 1.92 g, netilmicin 150 mg (i.m.) and fosfomycin
trometamol 3 g. The 4-quinolones are effective new antimicrobial agents
and promise to be useful in single dose regimens for simple, uncompli-
cated UTIs. We report two prospective, randomized trials comparing a
single 400 mg dose of either enoxacin or fleroxacin with a single 600 mg
dose of trimethoprim. The enoxacin study was double-blind and the
fieroxacin study single-blind. The results are shown in the Table:
Trimethoprim
Study
600 mg stat
No. Cured
Quinolone 400 mg stat
No. Cured
1 26 22 Enoxacin 29 20
2 18 16 Fleroxacin 17 16
All drugs were highly effective for the treatment of Escherichia co/i, but
enoxacin cured only 4 of 9 patients infected with Staphylococcus
saprophyticus. Side effects were minimal. Single dose therapy is
recommended as the treatment of choice for bacterial cystitis and
asymptomatic bacteriuna in general practice. The new quinolones
appear to be highly effective when used in single dose regimens.
Human recombinant erythropoietin (rHuEPO) improves quality of life
in anemic hemodialysis patients. D.C.H. Harris, J.R. Chapman, J,H.
Stewart, S. Lawrence, S.D. Roger, B.J. Nankivell, Renal Unit, West-
mead Hospital, NSW 2145, Australia. As the primary aim of rHuEPO
therapy is to improve quality of life, this was assessed before and after
6 months in 23 patients (15 male, aged 19 to 68) on maintenance
hemodialysis with a pre-treatment Hb of 67 2 g/liter ( SE). Target
Hb was 90 to 100 g/liter and assessment made using time trade off
(TFO), ANZDATA activity scale (AS), life satisfaction score (6 items,
0 to 7 each) and symptom questionnaire (36 times, 0 to 7). At 6 months,
Hb was 97 2 g/liter (P < 0.001 vs. 0 mon.) and rHuEPO dose 98± 9
units Lwkl IVI. There was a significant improvement in 'ITO (48
6 to 64 6, P < 0.01), AS (77 2 to 87 2, P < 0.001), and
satisfaction with leisure activity (P < 0.001), medical situation (P <
0.01), self (P < 0.05), sexual activity (P < 0.05) and employment/
housework (P < 0.05) but not family life. In respect to individual
symptoms present before therapy, there was improvement in only 5:
fatigue, appetite, depression, angina and dyspnoa, Functional capacity
also improved: 6 mm walking test (5.1 0.3 vs. 6.5 0.6 laps, P =
0.01) and performance with serial 7's (P < 0.05). In summary, despite
the relatively low target Hb and mean dose, quality of life and
functional capacity were clearly improved by 6 months of rHuEPO.
Proximal tubular cell Na transport in diabetes mellitus (DM) defined by
electron microprobe analysis. CA. Pollock, M.J. Field, T.E. Bostrom,
A.Z. Gyory, D.J.H. Cockayne, Department of Medicine and EM Unit,
University of Sydney, NSW 2006, Australia. To evaluate proximal
tubular Na transport and intracellular (IC) Na concentration during
glomerular hyperfiltration and hypertrophy in DM, combined clearance/
electron microprobe experiments were performed in Sprague-Dawley
rats. DM was induced by streptozotocin (60 mg/kg IV! in citrate buffer)
and control animals received citrate alone. Animals were studied 8 to 10
days later. Glomerular hyperfiltration, assessed by inulin clearance,
was confirmed in the diabetic animals compared with control (1.44
0.07 vs. 1.00 0.07 ml/min/l00 g; P < 0.001). Basolateral Na-K ATPase
activity was assessed by measuring IC rubidium (Rb) accumulation in
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individual proximal tubular cells, following infusion of isotonic RbCl
(0.5 mmollkg LVI over 30 seconds) at the conclusion of the clearance
studies. IC Na and Rb concentrations were determined in freeze dried
cryosections of the kidney using energy dispersive X-ray microanalysis
on a Phillips 505 electron microscope and analyzed using an EDAX
9900 microanalyzer. IC Rb concentrations were significantly higher in
the animals with DM vs. control (7.92 0.51 vs. 5.54 0.50 mmol/kg
wet weight; P <0.001), indicating increased entry of Rb into the cell via
enhanced basolateral Na-K ATPase activity. If this were the only
transport change occurring in DM, IC Na concentration would be
expected to fall. However IC Na concentration was higher in DM (19.52
0.56 vs. 17.75 0.39; P <0.01), indicating concomitant enhancement
of apical Na entry, in excess of basal exit. Increased Na transport from
the lumen in DM compared to control is also supported by micropunc-
ture data from our laboratory showing increased fractional reabsorption
of Na in the proximal tubule in DM. We conclude that hyperfiltration in
DM is accompanied by increased proximal Na reabsorption, character-
ized by enhanced Na transport at both the luminal and basolateral
membranes of proximal tubular cells. As IC Na concentration is higher
in DM it is likely the primary event is increased apical entry with
secondary stimulation of Na-K ATPase.
Effect of endothelin on sodium excretion in the rat. D. Thomas, T.O.
Morgan, P.J. Harris, Department of Physiology, University of Mel-
bourne, Victoria 3052, Austria. Endothelin, a potent vasoactive pep-
tide, has effects on sodium excretion but the site and mechanism of
action is uncertain. Endothelin receptors exist in glomeruli vasa recta
and proximal tubules. This study attempted to localize the site of action
of endothelin. Rats were anaesthetized with mactin and prepared for
micropuncture and infused with 0.9% NaCI 1.6 ml hr 100 g' body
weight. Three 20-mm urine collections were made and endothelin
infused at 30 ng kg min l; 2 more 20-mm collections were made.
Proximal tubule fluid reabsorption (Jv) was measured using a comput-
erized imaging modification of the shrinking drop micropuncture tech-
nique. BP rose from 100 4 to 128 4 to 128 3 mm Hg and stayed
elevated. Urine sodium excretion rose from 0.18 0.10 mollmin to
1.58 0.50 mol/min in the 3rd endothelin collection period. Proximal
tubule reabsorption decreased from 3.5 0.2 to 2.6 l0 mm3 mm2
In a separate set of experiments, the capillaries surrounding the
proximal tubule being studied by split drop were infused with an
artificial plasma-like perfusion solution. Endothelin was added to the
perfusate and proximal tubule reabsorption (iv) measured. Endothelin
10—12 M was not different to control. There was a dose dependent
increase in Jv of 16% with 10— 10 29% with i0 and 41% with l0 M.
Thus it appeared that endothelin both stimulated and decreased proxi-
mal tubule reabsorption. The decrease in reabsorption when infused
systematically may reflect effects on other hormonal system such as
ANF or ALL which have effects on the proximal tubule that overcome
the direct stimulating effect of endothelin.
Renin synthesis in hydronephrotic kidneys. G.L. Barrett, T.O. Mor-
gan, D. Alcorn, Department of Physiology, University of Melbourne,
Victoria 3052, Australia. Renin secretion and synthesis are controlled
by a number of factors. On secretion, the baroreceptors, the macula
densa, the sympathetic nervous system and circulating Ang IL all exert
an effect. We have shown that Ang II has a direct effect on synthesis by
altering mRNA for renin. However, the increase in renin synthesis and
secretion caused by the absence of Ang II can be inhibited by an
increased body sodium. The mechanism of this effect is unknown and
we studied the effect of the macula densa on this event. The left kidney
of 8 to 10 week, male BaIb C mice was tied and studies conducted 8
weeks later when this kidney was hydronephrotic and the other kidney
had hypertrophied. One group of mice (N 12) was kept on a control
diet while the others were made sodium deplete by a low salt diet for 7
days and frusemide 50 tg l.P on day 0, 1, 2, 3. The hydronephrotic
kidney had a decreased total renin mRNA and renin content but the
mRNA and renin concentration were the same or higher due to the
reduced amount of renal tissue (mRNA conc. 100 vs. 123, renin conc.
561 vs. 1121 mg AI/hr/g, P <0.01). The ratio of renin: mRNA was 5.6
in the control kidney and 9.0 in the hydronephrotic kidney. Sodium
depletion caused a rise in plasma renin. mRNA and renal renin
increased in both the control and the hydronephrotic kidney. In the
control kidney mRNA 100 to 290 units/g, renin 561 to 1072 g AL/hr/g,
P <0.01. In the hydronephrotic kidney, 123 to 449 units/g and 1121 to
1987 sg AI/hr/g, P < 0.01. The increase were similar in both kidneys.
Before and after sodium loading, the ratio of renal renin to mRNA was
higher in the hydronephrotic kidney. These results indicate that the
response to mRNA is similar in hydronephrotic and normal kidneys and
that the macula densa is not critical for this stimulation. However, it is
possible that the macula densa does exert a regulatory effect on renin
synthesis after mRNA.
Protein restriction reduces remnant kidney (RK) hypermetabolism.
D.C.H. Harris, Y.C. Tay, Renal Laboratory, Westmead Hospital,
Westmead, NSW 2145 Australia. The reduction of RK hypermetabo-
lism by phosphate restriction, in particular that portion independent of
net sodium reabsorption (TNa+), suggests that phosphate restriction
may slow disease progression in RK by reducing hypermetabolism. To
examine the effect on hypermetabolism of another protective manoeu-
vre, protein restriction, isolated RK were perfused with 5 mrvi glucose
and amino acids after 4 weeks of pairfeeding 12% casein (LP) or 40%
casein (HP). Protein restriction reduced urinary excretion of protein
(17.4 2.8 vs. 40.4 8.1 mg/24 hr, LP vs. HP, SE, P <0.02) urea(2.67 0.29 vs. 15.73 1.49 mmol/24 hr, P < 0.001) and water (21.8
1.9 vs. 42.1 3.7 ml/24 hr, P <0.001), but not Na, K or creatinine.
Body and kidney weights were no different. Protein restriction reduced
GFR (100 27 vs. 317 56 jsl• min g, P <0.01), TNa+ (8.74
4.38 vs. 38.83 8.32 mol min' g, P <0.001) and net ammonia
production (0 to 30 mm, 0.16 0.05 vs. 0.32 0.03 smol min' g',
P < 0.05) but not net glucose consumption. In conclusion, (1) in
contrast to phosphate restriction, protein restriction reduces TNa+
dependent hypermetabolism, and (2) both TNa+-dependent and TNa*
independent hypermetabolism may be crucial to disease progression in
RK.
Sodium: A regulator of VIP release and metabolism. K.A. Duggan, S.
Shelley, G.J. Macdonald, Department of Nephrology, Prince Henry
Hospital, Sydney, NSW 2036, Australia. Vasoactive intestinal peptide
(VIP) has been shown to be natriuretic in the rat, rabbit and dog.
Gastric sodium loading releases VIP and decreases its metabolism by
the liver but the effect of intravenous (i.v.) sodium loading on VIP
release and metabolism have not been studied. To investigate the effect
of i.v. sodium on VIP release, male New Zealand white rabbits with
chronic indwelling portal venous catheters were equilibrated on normal
and low sodium diets. Plasma VIP levels were measured prior to and
following an intravenous sodium load of 1.5 mmol kg' (as 0.513 M
saline). In rabbits on the low sodium diet, plasma VIP decreased from
18.2 2.4 pmol l' before the load to 10.1 2.2 pmol I' 15 mm after
the sodium (P < 0.005). No change occurred after sodium administra-
tion by either route in the normal salt group or after portal administra-
tion in the low sodium diet group. To determine whether the decrease
in VIP levels resulted from increased metabolism or decreased secre-
tion, metabolic clearance studies of VIP were performed before and
after an iv. sodium load in rabbits equilibrated on normal and low
sodium diets. In the low salt diet group, metabolic clearance rate (MCR)
increased from 167.2 50.6 to 316.7 47.0 ml kg'min1 after the i.v.
sodium (P < 0.025) and the secretion rate (SR) increased from 1.56
0.51 to 2.32 0.49 mmol min' (P < 0.05). In contrast, in rabbits on a
normal salt diet, MCR decreased from 247.9 12.6 to 159.6 18.8 ml
kgmin1 (P < 0.01) while SR did not change significantly. We
conclude, therefore, that both chronic sodium intake and acute sodium
administration contribute to the regulation of VIP release and metabo-
lism and suggest that this provides evidence for a role for VIP in sodium
homeostasis.
Tubular sodium handling and tubuloglomerular feedback (TGF) in
renal hypertrophy. C.A. Pollock, JR. Lawrence, M.J. Field, Depart-
ment of Medicine, University of Sydney, Concord Hospital, NSW2139,
Australia. In order to assess the changes in tubular Na handling and
TGF responses that occur in association with glomerular hyperfiltra-
tion, renal micropuncture studies were performed in 2 rat models of
renal growth: streptozotocin (STZ)-induced diabetes mellitus (DM),
and compensatory hypertrophy (CH). DM, of a severe (BSL 18 to 25
mmol/liter, N = 9) or moderate (BSL 13 to 18, N = 6) degree, was
induced by STZ (60 mg/kg IVI in citrate buffer), while control animals
received citrate alone (BSL < 10, N = 7). CH was induced by
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uninephrectomy + ligation of the vessels to the lower 1/3 of the
contralateral kidney (1 + l/3Nx, N = 8), uninephrectomy alone (UNx,
N = 5) or sham nephrectomy (SNx, N 4). Both late proximal (LP)
and early distal (ED) estimates of SNGFR were higher in severe DM
(85.67 6.0 & 46.1 4.7 nllmin) vs. moderate DM (53.9 3.9 & 27.6
2.2 nI/mm) and control (36.6 2.7 & 23.2 1.4 nI/mm; P < 0.001).
TGF activity, measured as the difference between LP and ED measure-
ments of SNGFR, was significantly elevated in severe DM vs. control
(P < 0.05). A similar pattern of hyperfiltration was observed in the
model of CH, SNGFR being 79.6 4.9 (LP) & 46.3 1.9 (ED) nI/mm
in the 1 + 1/3 Nx, 63.1 3.2 & 39.8 2.5 nI/mm in the UNx and 41.0
4.4 & 29.2 2.9 in the SNx (P < 0.001). TGF activity was higher in
the nephrectomized animal groups compared with control (P < 0.001).
Tubular Na transport was higher in both models of glomemlar hyper-
filtration compared with their respective controls as evidenced by 1) a
decrease in fractional delivery of Na at the LP (P < 0.05 in DM, P <
0.05 in CH) and ED (P < 0.001 in DM, P < 0.05 in CH) sites, and 2) an
elevated rate of Na reabsorption up to the ED tubule (P < 0.002 in DM,
P < 0.005 in CH). These data suggest that glomerular hyperfiltration
observed in 2 diverse models of renal hypertrophy is associated with
enhanced proximal and 1oop reabsoprtion of Na. These changes in Na
transport may have a role in the observed activation of TGF which
serves to limit the rise in GFR in both models. The resetting of the TGF
curve results from other factors which remain to be defined.
A low sodium diet reduces hyperfiltration in the streptozotocin diabetic
rat. T. Allen, M. Cooper, D. Casley, G. Jerums, Endocrine Unit,
Department of Medicine, Austin Hospital, Heidelberg, Victoria, Aus-
tralia. Early experimental diabetes is associated with an increase in
glomerular filtration rate (GFR) and kidney size. This study has
evaluated the effects of a low sodium diet on the renin-angiotensin
system and GFR in streptozotocin diabetes. Male Sprague-Dawley rats
weighing 225 to 275 g were fasted overnight, injected with either 60
mg/kg (i.v.) streptozotocin or citrate buffer, and then randomized to
receive either a low sodium (LS) diet or a normal sodium (NS) diet.
Four weeks later, animals were injected with mTcDTPA and decap-
itated after 43 minutes for collection of trunk blood and determination
of GFR, plasma glucose (PG) and plasma angiotensin II (Ang II). Right
kidney weight was recorded (RKW). The results are shown as mean
SEM except for Ang II (geometric mean):
N
PG
mi
GFR
mi/mm
RKW
g
Plasma
Ang II
pg/mi
Diabetic + LS
Diabetic + NS
10
11
28 2
34 3
3.5 0.2a
4.6 0.3
1.20 0.o2
1.59 0.08
l52.8a
37,3t
Control + LS
Control + NS
16
15
7 1
8 1
2.5 0.la
3.1 0.1
1.03 0.04
1.10 0.03
260.0
156.0
a P < 0.01 vs. respective control; b P < 0.01 vs. Control + NS
GFR was elevated in diabetic rats on a normal sodium diet, when
compared with control rats (P < 0.001). The low sodium diet was
associated with a decrease in GFR, KW and body weight (BW) in
diabetic rats (BW: diabetic + LS, 258 6 g vs. + NS, 303 8; P <
0.001) and control rats (BW: control + LS, 301 2 g vs. + NS, 353
6; P < 0.01). Plasma levels of Ang II were significantly elevated in
diabetic rats on a low sodium diet, and marginally elevated in control
rats on the same diet (P = 0.09). There was a significant, negative
correlation between plasma Ang II levels and GFR (r = 0.52, P =
0.0009). In conclusion, a low sodium diet reduced the hyperfiltration
associated with early diabetes. This may be secondary to altered
intraglomerular haemodynamics mediated by increased plasma Ang II
levels. Alternatively, this observation may result from a generalized
effect of a low sodium diet on growth.
This work was supported by the Juvenile Diabetes Foundation of
Australia
Renal corticomedullary portal systems in the whiptail wallaby, tammar
wallaby, koala, platypus, flying fox and human. C.H. Burger, R.B.
Cross, Department of Physiology and Pharmacology, The University of
Queensland, St Lucia, QId 4067, Australia. The blood supply of the
renal medulla is usually regarded as being distinct from that of the renal
cortex. This has created difficulties in explaining how vasoactive
substances elaborated in the medulla might regulate cortical blood flow
(McGiff, 1980). Renal microcapillary organizations were studied in
several species of mammals after intra-arterial injection of the kidney
with colored silicone rubber. Thick cleared slices of the kidney were
prepared and the convoluted tubules were visualized by microinjection
of medium of contrasting color into the Bowman's capsule. These
studies revealed extensive communications between the microcircula-
tion of the medulla and cortex. In the type A communication seen in the
whiptail wallaby, koala, platypus and human, ascending venous vasa
recta anastomose with the capillary plexus which supplies the medul-
lary rays. This in turn communicates freely with the wider cortical
microcirculation. In the tammar wallaby and flying fox, a type B
communication is formed by a small proportion of ascending venous
vasa recta which ascend through the medullary rays to fan out into a
secondary capillary system which anastomoses with the capillaries of
both the medullary rays and the general cortical circulation. The
occurrence of these portal systems in so many different species suggests
that they are probably a common feature in all mammals.
McGiffJC: Clin Sci59:l055—1165, 1980
The hemodynamic and renal effects of endothelin (ET) in the conscious
sheep. A.F. Reid, C. Kamphuis, J.P. Coghlan, J.G. McDougall, D.G.
Parkes, B.A. Scoggins, J.A. Whitworth, N.A. Yates, Howard Florey
Institute of Experimental Physiology and Medicine, Parkville, 3052 and
Department of Nephrology, Royal Melbourne Hospital, Victoria 3050,
Australia. Intravenous (i.v.) infusion of ET has been shown to produce
potent vasoconstriction in the conscious sheep. This study investigates
the renal and hemodynamic effects of i.v. infusion of ET in conscious
sheep. Five conscious adult sheep received ET (iv 15 zg/hr) for 24
hours. There was a sustained increase in mean arterial pressure (MAP)
after 24 hours of ET infusion, 64 5 to 73 6 mm Hg (P < 0.05) with
no change in heart rate (HR). Cardiac output (CO) was significantly
decreased after I hour, 5.4 0.4 to 4.9 0.3 liter/mm (P < 0.01) and
remained decreased throughout the entire infusion period, 4.5 0.3
liter/mm at 24 hours (P < 0.001). The decrease in CO was associated
with an increase in total peripheral resistance, 10.7 0.6 to 14.8 0,7
mm Hg/liter/mm (P <0.001) after 24 hours of ET treatment. Infusion of
ET (i.v. 50 sg/hr) for 60 mm into five sheep increased MAP from 74
2 to 98 7mm Hg (P < 0.001), while HR decreased, 71 4 to 45 2
beats/mm (P < 0.001). Urine flow increased from 1.1 0.5 to 3.2 1.7
mI/mm (P < 0.05), with no change in sodium excretion. Effective renal
plasma flow (ERPF) significantly decreased from 335 33 to 190 69
mI/mm (P < 0.01), whilst there was no change in glomerular filtration
rate (GFR). Hematocrit increased from 24 1 to 28 1% (P < 0.05).
These studies demonstrate that ET produces a sustained pressor
response mediated by a marked vasoconstriction. The differential effect
of ET on ERPF and GFR is consistent with ET exerting a greater
vasoconstrictor effect on the efferent rather than on the afferent
arteriole.
Renal effects of endothelin (ET) in anaesthetized rats. J. Zhuo, P.J.
Harris, S.L. Skinner, Departments of Physiology and Medicine, Uni-
versity of Melbourne, Parkville, Victoria, Australia. Endothelin has
been reported to be a potent systemic vasoconstrictor, but its renal
actions remain unclear. In anaesthetized rats we have investigated
systemic and renal responses during constant infusions of low doses of
ET (1 & 10 ng/min/kg) using clearances of PAH, polyfructosan and
lithium to assess renal hemodynamics and tubular function. ET (low
dose) induced a transient (10 mm) increase in MAP (17 5 mm Hg;p).
MAP fell below control (14 5 mm Hg;p) 30 mm after FT infusion
began and hypotension persisted throughout infusion. RPF increased
by 46% (p) but GFR was unchanged while FF and RVR increased
significantly. V and FEH increased 5-fold and UNaV and FENa
increased by 10-fold (p). FK and TCH2O were unaltered. End proximal
fluid delivery (CL) doubled (p) although APR did not change. Fractional
proximal and distal sodium reabsorption decreased by 10 to 20% (p) and
5% (p), respectively. These changes were similar with both doses and
persisted throughout the 60 mm recovery period. Thus, whole kidney
and proximal glomerulo-tubular balance were impaired by ET. We
conclude that at low concentrations ET is natriuretic due to inhibition of
sodium transport in the proximal and distal nephron.
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Inhibition of angiotensin II production or receptor blockade inhibits the
natriuresis of atrial natriuretic peptide in the rat. S. Reddy, N. Salipan-
Moore, C. Cochineas, A.Z. Gyory, Departments of Medicine, Univer-
sity of Sydney and Rena! Medicine, The Royal North Shore Hospital, St
Leonards, 2065 Australia. We have previously shown that concurrent
converting enzyme inhibition (CEI) attenuated the natriuretic actions of
synthetic atrial natriuretic peptide (ANP). Returning the mean arterial
pressures (MAP) with simultaneous noradrenaline (NA) infusion
towards control (C) levels did not return the natriuresis of ANP. We
decided to examine whether this effect of CEI was Ang II receptor
specific or through other peptides also affected by it, or through its
MAP lowering effect. First, in repeat experiments Saralasin (SAR, an
Ang II antagonist) was infused from the beginning of the experiments
followed by ANP and then by NA. Second, Ang I! infusion (at 10 '°M)
was superadded onto CEI instead of NA. Substances were infused into
Wistar rats through the jugular vein, MAP (mm Hg) measured through
the carotid artery, urine collected from ureters. GFR (ml/min/g kw) was
measured with '4C inulin. Two control periods were followed by two
ANP and two NA or Ang II periods. Fractional excretion of sodium
(FENa, mean SE, Table) was reduced significantly by CE! (MAP = 75
2,GFR = 1.55 0.06) and SAR(MAP = 68 2,GFR = 1.50 0.18)
in the presence of ANP against C( = vehicle, MA = 90 3, and GFR
= 1.51 0.04). Increasing the MAP to the auto-regulatory range with
A!! returned FENa to control (MAP = 95 3, GFR = 1.52 0.08)
whereas with NA (+ CE! or SAR) it did not (MAP for CEI+ NA = 107
2, GFR = 1.26 0.26, MAPforSAR + NA = 108 4, GFR = 0.71
0.21). Other peptide systems affected by CE! but not SAR probably
account for significant differential effects of CEL and SAR (eg: on GFR)
in the presence of NA.
ANP NA Ang II
C 0.17 .03 1.57 .16 2.34 .36 —
CE!
SAR
0.56
0.11
.09
.05
1.12
0.97
14b
.13b
1.30
1.80
.l9a
.38
2.81 ,43C
—
P < 0.05, b P < 0.01 from C; P < 0.01 from NA
These results indicate that CEI interferes with the natriuretic actions of
ANP through All receptors and this is largely independent of changes
in MAP in the autoregulatory range.
How useful is the fractional excretion (FE) of lithium as a marker of
proximal tubular (PT) function in diabetes mellitus (DM)? C.A. Pollock,
J.R. Lawrence, M.J. Field, Department of Medicine, University of
Sydney, Concord Hospital, NSW2139, Australia. The usefulness of the
FE of Li as a marker of PT sodium reabsorption, and its relationship to
the hyperfiltration observed in DM, was assessed. To avoid giving
exogenous Li salts, endogenous Li was assayed in plasma and urine by
flameless atomic absorption spectrophotometry. FELl was measured in
rats before the induction of streptozotocin (STZ) DM and 4 to 5 days
later, at which time the animals had confirmed hyperfiltration and were
in a net positive Na balance (P < 0.05). Renal micropuncture was
performed 6 to 8 days after STZ, and late proximal (LP) tubular [Na]
was assayed. Concurrent measurement of inulin allowed estimation of
LP fractional delivery (FD) of Na. Similar studies were performed in
control animals (C), and in diabetic rats treated with phlorizin (P-DM)
to block proximal Na-glucose cotransport. Hyperfiltration occurred in
the STZ DM animals vs. C (1.17 0.06 vs. 0.92 0.07 ml/minIlOO g; P
<0.05). FD of Na to the LP site was reduced in STZ DM vs. C (42.9
2.3 vs. 50.1 1.6%; P < 0.05). A concomitant decrease in FEL was
also observed in STZ DM (1.6 0.2 vs. 2,6 0.7%, although this was
not significant (P = 0.23). P-DM had no change in GFR compared with
C (0.99 0.03 vs. 0.92 0.07 ml/min/l00 g). LP FD of Na increased in
the P-DM compared with C (55.8 3.0 vs. 1.6; P < 0.05), and a
concomitant although not significant increase in the FE of Li occurred
(1.9 0.8 vs. 0.6 0.2%, P < 0.23). We conclude that the FE of
endogenous Li is not a sensitive marker of proximal tubular Na
reabsorption, as shown in both the STZ DM rat, where PT Na
reabsorption is increased, and in phlorizin treated DM, where PT Na
reabsorption is decreased.
Charge selectivity in kidney ultrafiltration is associated with cyclohex.
imide-sensitive glomerular uptake of macroanion transport probes. W.D.
Comper, M. Tay, Department of Biochemistry, Monash University,
Clayton, Victoria 3168, Australia. This study sets out to investigate the
mechanism of charge selectivity in kidney ultrafiltration as the biophys-
ical approach has been found incapable of explaining the in vivo
fractional clearance data of charged dextran derivative transport probes
(Zamparo, 0., & Comper, W.D., Kidney Int, in press). We test the
hypothesis that cellular uptake is involved by examining the clearance
of [3H]dextran sulphate in the isolated perfused kidney (IPK) system.
The !PK exhibits partial charge selectivity function as compared to in
vivo when studying the clearances of dextran and dextran sulphate.
When cycloheximide (a specific inhibitor of de novo protein synthesis)
is present in the perfusate the transport charge selectivity is lost.
Cycloheximide effect appears specific to charge selectivity as it did not
affect the GFR or dextran fractional clearances. !n control systems,
isolation of perfused glomeruli show a very significant accumulation of
[3H]dextran sulphate (two orders of magnitude higher than [3H]dextran
or [3H]inulin perfused under the same conditions). The glomerular
accumulation of [3H]dextran sulphate has a half-life of 2 to 4 mm as
studied in cold chase experiments. The accumulation is significantly
inhibited by cycloheximide. The conclusion from this work is that
glomerular charge selectivity for macroanions is associated with rapid
uptake and release of the probe by glomerular cells which will then
lower the effective concentration of the probe at the glomerular
basement membrane/capillary interface.
The effect of decreased plasma oncotic pressure (Ponc) on glomerular
filtration and sodium (Na) excretion. C. Dallemagne, R.B. Cross, N.
Yesberg, Z. Endre, S. Fleming, Department of Public Health &
Nutrition, Queensland University of Technology, Queensland 4000;
The University of Queensland; and Royal Brisbane Hospital, Australia.
From Starling's law changes in Ponc should alter GFR and Na excretion
but the interrelationship between these variables is not well established
experimentally. The effect of lowering Ponc was studied in 5 conscious
merino ewes by removing plasma (36.2 3.7 mI/kg) and replacing this
with Hartmann's solution (88.8 8.2 mI/kg). There was a close
correlation between plasma protein concentration (P) and Ponc (r =
0.99). Plasma renin activity and concentrations of aldosterone and ANF
were not altered significantly 0 and 24 hr after plasmapheresis. The
effect of lowering Ponc on other parameters [mean (sEM)] is tabulated:
Post-
Control treatment Next day
Ppg/d1 6.5(0.2) 27(03)b 46(03)b
ERPF mI/mm 367 (31) 234 (25)b 333 (36)
GFR mI/mm 62.0 (8.8) 63.3 (7.0) 68.6 (11.8)
FF 0.17 (0.02) 0.28 (0.02)' 0.20 (0.02)a
MAP mm Hg 99 (5) 83 (4) 101 (8)
CVP mm Hg 1.7 (0.8) 0.2 (0.8) —0.3 (0.8)
FENa 1.7(0.5) 4.8(l.l)a 2.9(0.5)
Significant difference from control a p < 0.05, b p < 0.01
Despite the decrease in ERPF, GFR was maintained by an increase in
FF associated with the decrease in Ponc. FENa was increased despite
unchanged levels of MAP and hormones known to affect Na excretion,
and probable volume depletion. This suggests that the natriuresis was
mediated by the decrease in Ponc within peritubular capillaries and/or
inhibition of tubuloglomerular feedback. Acute alterations in Ponc have
effects on renal function which may be of considerable clinical signifi-
cance.
Retinoic acid inhibits mesangial cell growth through a G protein
dependent mechanism. Y. Kakizaki, N. Kraft, R.C. Atkins, A. Argiles,
T. Octaka, Department of Nephrology, Prince Henry's Hospital,
Melbourne, 3004 Australia. Retinoic acid (RA) is a natural retinoid
(vitamin A derivative) which modulates growth and differentiation of
several cells. We have previously suggested that RA participates in
human compensatory kidney growth and reported its effects on rabbit
and human kidney epithelial cells. To progress in the study of kidney
cell response to RA we analyzed its effects on a rat mesangial cell line.
The cells were cultured in RPMI 1640-10% FCS in the presence or
absence of l0 M RA. Thymidine incorporation (T!) was decreased in
RA cultures by 12 2% (5 experiments with 12 replicates; P < 0.008).
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The addition of bordetella pertussis toxin (BPT) (blocker of G protein)
(10 ng/ml) inhibited this effect (—1.6 4,6%; NS). We have previously
reported that epidermal growth factor (EGF) stimulates TI in these
cells. In this study, BPT did not block EGF activity. When EGF was
used together with RA an inhibitory effect was again observed with
respect to non-treated controls (average 15 6%, significant in 2/3
experiments). The addition of BPT reversed the inhibition, causing an
11 5% increase in TI (significant in 2/3 experiments). Essentially
similar results were obtained with cells grown in serum free medium.
We conclude that RA has at least two distinct and opposing effects on
kidney cells: a stimulatory action on epithelial cells which is insensitive
to BPT and an inhibitory effect on mesangial cells which is G protein
dependent. The interaction between RA and EGF may also be depen-
dent on a G protein transduction pathway.
Purification of microvascular endotheliuim from human late pregnancy
decidua. E.D.M. Gallery, C. Jackson, L. Schreiber, Royal North Shore
Hospital, St Leonards, Sydney NSW 2065, Australia. Normal preg-
nancy involves invasion of maternal decidua by cytotrophoblast, pro-
ducing structural and functional alterations of this and surrounding
tissues, not seen in women who develop pregnancy-associated hyper-
tension (P-AH). To allow examination of decidual vascular tissue
function in vitro, we have developed a rapid and simple technique for
isolating and culturing pure human decidual microvascular endothelial
cells. The cells are first isolated by extracting capillary segments from
enzyme-treated cubes of decidua then purified by virtue of selective
binding of dynabeads coated with lectin Ulex Europaeus I (UEAI).
They are separated from contaminating cells using a magnetic particle
concentrator and plated down in gelatin-coated tissue culture dishes.
The procedure takes 2 hours. These cells are characterised as endothe-
hal by virtue of (i) binding to UEAI, (ii) formation of confluent
cobblestone monolayer in culture, (iii) factor VIII binding studies. This
new technique will allow us to study basal microvascular endothelial
cells' production rates of vasoactive, pro- and anti-coagulant factors,
and the effects of known modulators of serum and soluble cell secretory
products. It has applicability not only to pathophysiology of utero-
placental abnormalities in pregnant women with hypertension and
renal disease, but may have wider applicability in other areas of
nephrology.
Differential inhibition of proximal tubular volume flux with artificial
and native harvested tubular fluids: Early and late clip models of volume
expansion in rats. S. Reddy, C. Cochineas, T.E. Boström, M.J. Field,
D.J.H. Cockayne, A.Z. GyOry, Department of Medicine and Renal
Medicine (The Royal North Shore Hospital) and EM Unit, University of
Sydney, NSW2065, Australia. Earlier experiments from this laboratory
demonstrated significant differences in proximal tubular Na transport
inhibition during volume expansion depending on whether artificial
(AF) or native harvested tubular fluid (HFT) was used. In the present
blinded experiments, the shrinking drop technique was used to measure
volume flux (Jv) in the early (EC) and late clipped (LC) models of saline
volume expansion (VE) with AF alternating with HTF. Inhibition of
transport with AF & HTF in EC and with AF in LC (not significantly
different) was, on average, 70%. The significantly greater inhibition of
Na transport at 47% with HTF but not AF during VE in LC, suggests
mechanisms other than physical forces responsible for Na transport
inhibition during YE (Figure). Reaspirated stationary fluid droplets
were analyzed by elec-
tron microprobe X-ray
techniques. There were
E.i1vCE Lit. CuD no significant differ-
ences between AF and
A3tIfti.I i4.,v.s.d Tubut.,LJ Fluid IJ HFT in Cl concentra-
.1. tions during Ne or YE.
These results strongly
imply the presence of
an additional factor, or
factors, other than
YE which inhibit prox
____________
Lj physical forces duringem 37 a' imal tubular Na trans-
;n. port, and is present in
YE Eep.nd.d YE Eep.nded HFT but not AF.
Electron microprobe X-ray (EMPX) elemental analysis of proximal
tubular cells in acute saline volume expansion in rats: Evidence for
inhibition of the sodium pump. A.Z. GyOry, T.E. Bostrom, J. McNay, S.
Reddy, M.J. Field, D.J.H. Cockayne, Department of Medicine and
Renal Medicine (The Royal North Shore Hospital) and EM Unit,
University of Sydney, NSW, Australia. It was previously shown from
our laboratory that intracellular Na and Cl rose during mannitol-saline
volume expansion (MVE), implying inhibition of the Na pump. During
MVE pencellular osmolality is elevated and this (through cell shrink-
age) could have partly accounted for the above result. These experi-
ments were repeated with saline YE (SVE) where pericellular oncotic
pressure is expected to fall. Intracellular element concentrations were
measured by EMPX in control, non-expanded (C), and SYE rats.
During SVE intracellular Na and Cl increased by +3.3 and +8.6
mmol/kg wet wt (P < 0.001), while K remained unchanged (—2.6
mmol/kg wet wt, P < 0.2), a relative decrease in the face of cell
shrinkage when compared to C (Figure). Cell shrinkage by tissue dry
weight analysis was 12% (P < 0.0001). The cell shrinkage was con-
firmed by morphometric analysis of tubules (TRACOR-Northern
TN8502), cell area being 17% smaller in SVE than C (P < 0.007). These
results confirm our previous findings of an elevation of intracellular Na
and Cl concentrations during YE, and once again imply inhibition of the
Na pump during YE. The cell shrinkage (also found by others) may be
due to raised intra-renal pressures.
5/6 Nephrectomy by ligation of branches of the renal artery or resection
of the poles of the kidney: Are the models all the same? N. Gretz, P.
Drescher, J.J. Lasserre, M. Strauch, Clinic of Nephrology, University
ofHeidelberg, Klinikum Mannheim, 68 Mannheim, Federal Republic of
Germany. The so-called 5/6 nephrectomy model (remnant model)
consists of at least 2 different models: resection of the poles of 1 kidney
(resection model ER]) or ligation of branches of the renal artery (ligation
model [LI), followed by unilateral nephrectomy (UNx). The course of
hypertension and its cause(s) in R and L are still unknown, The aim of
this paper is to evaluate the time course of hypertension and its
underlying cause(s) in R and L. In a short time trial we randomly
allocated 40 male SD rats to R or L. Concerning bashine data there was
no difference in the 2 groups. Serum creatinine and urea rose sharply
after UNx followed by a continuous decrease. In R a positive water
balance occurred during the first weeks, followed by a negative one. In
contrast there was negative water balance in L indicating water
depletion. Blood pressure (BP) rose after UNx in both models. In
contrast to L, BP returned to normal in R, while it slowly further
increased in L. Plasma renin activity was significantly different in the 2
groups: depressed in R and high/normal in L. These findings were
confirmed in a 6 and 12 months trial (N = 40 in each trial). Furthermore,
differences in glomerular size were detected between the two models,
Our data indicate that with respect to BP and structural changes
important differences between the models exist.
The effects of perindopril vs. triple therapy on albuminuria in nor-
motensive diabetic rats. R.C. O'Brien, D. Papazoglou, T. Allen, G.
Jerums, Department of Medicine, Austin Hospital, Heidelberg, Victo-
ria 3084, Australia. The administration of angiotensin converting en-
zyme (ACE) inhibitors to diabetic rats has been shown to ameliorate
albuminuriai, and it has been recently suggested that despite equivalent
hypotensive effects, these agents are more effective in reducing albu-
minuria than other antihypertensive drugs2. However, another report
comparing ACE inhibitors with conventional antihypertensive drugs
found equal reduction in diabetic albuminuria with both regimens3. The
aim of this study was to compare the effects of the ACE inhibitor
Perindopril to conventional antihypertensive therapy, on blood pres-
(MnttSEW 0 c..s • SYF ft—tm I" Ij.
"ii I • 1.o.1 I—I -S-
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sure, GFR and albuminuria in normotensive streptozotocin diabetic
rats. Diabetes was induced at 6 weeks in male Sprague-Dawley rats,
and treatment was then commenced with Perindopril 2 mg/liter in
drinking water (P) N = 8,or triple therapy with hydrochlorothiazide 25
mg/liter, reserpine 2 mg/liter, and hydralazine 25 mg/liter (T) N = 9.
Twelve diabetic animals received no treatment (D). Blood pressure was
reduced equally by P and T (P < 0.05 vs. D), and albuminuria was also
reduced in both treatment groups at weeks 16, 24 and 32 (P < 0.001 vs.
D). There was no difference in GFR or glycemic control, and the results
for week 32 are summarized in the Table.
Group
Blood
pressure
mm Hg
Albuminuria
pg/24 hrs
Blood
glucose
mmol/liter
GFR
mi/mm
P 133 2 2.2 35.1 3.3 3.4 0.1
T 138 3 1.7 28.5 2.8 3.4 0.3
D 148 6 15.2 31.2 2.6 3.5 0.2
Data expressed as mean SEM. Albumin expressed as geometric mean.
These data confirm that antihypertensive treatment is effective in
reducing albuminuria in normotensive diabetic animals. The effect
appears to be due to reduction in systemic blood pressure, rather than
to a specific effect of ACE inhibition.
'Zatz R et al Proc Nat Acad Sci USA 82:5963, 1985
2Anderson S et al Kidney mt 36:526—536, 1989
3Cooper M et al Proc 13th IDF, Elsev Sc PuIb By, 1989
The role of calcium channel blockade in the hypertensive response to
cyclosporine in sheep. J.J. Tresham, J.A. Whitworth, B.A. Scoggins,
W.M. Bennett, Howard Florey Institute of Experimental Physiology
and Medicine, Parkville 3052; Department of Nephrology, Royal Mel-
bourne Hospital, Parkville 3052; Department of Medicine, Oregon
Health Sciences University, Portland, Oregon, USA. Hypertension is a
major problem with cyclosporine (CsA). Sheep show a rapid rise in
mean arterial pressure (MO 2 mm Hg) after intravenous administra-
tion of CsA, at 6 mg/kg/day over 5 days, and this is associated with a
rise in peripheral resistance. Nephrotoxicity is not a feature of CsA-
induced hypertension in this species. Calcium channel blockers are
widely used in the treatment of hypertension in renal allograft recipi-
ents. This study reports the use of nisoldipine (NIS) to investigate the
role of Ca-induced smooth muscle contraction in CsA-induced
hypertension in conscious sheep. After a 3-day control period (C), NIS
(24 mg/day) was infused iv. alone for 24 hrs (El), followed by 5 days of
NIS plus CsA (6 mg/kg/day) (E2-E6). With NIS atone, mean arterial
pressure (MAP) was unchanged, heart rate (HR) rose from 60 2
beats/mm (c) to 102 9 beats/mm (P  0.001), peripheral resistance
(TPR) fell from 15.8 0.5 (C) to 11.7 0.5 mm Hg/mi/mm (P 0.001)
and stroke volume (SV) fell from 73 4 mI/beat (C) to 60 5 mI/beat
(P 0.01). With NIS + CsA, MAP rose from 67 1 mm Hg (C) to 82
2 mm Hg on E6 (P 0.001), HR remained high to peak at 136 11
beat/mm (P 0.001) on E6, TPR was only significantly different on E5
when it was 19 1 mm Hg/mI/mm (P < 0.05) and SV fell to 34 4
mi/beat (P < 0.001) on E6. Both plasma [Nai and [K] fell significantly
throughout NIS + CsA, as did urinary K excretion. Urinary volume
and Na excretion rose during the combined infusion. Renal plasma
flow, measured on E6, was not different from control, but glomerular
filtration rate increased and filtration fraction rose. Thus, NIS failed to
alter the hemodynamic responses to CsA in conscious sheep. The
mechanisms by which CsA increases blood pressure in the absence of
reductions in renal haemodynamics remain to be elucidated.
Stimulation of active renin in pregnancy-induced hypertension. M.A.
Brown, V.C. Zammit, D. Adsett, Department of Renal Medicine, St
George Hospital, Kogarah, NSW 2217, Australia. Pregnancy-induced
hypertension (PIH) is characterized by reduced and suppressible ma-
ternal plasma active renin concentration despite reduced plasma vol-
ume. To determine whether this represents an inability to stimulate
renin, both active (PRC) and inactive (iPRC) plasma renin concentra-
tions were measured by radioimmunoassay of angiotensin I before and
after upright posture in normal third trimester primigravid women (NP),
women with PIH and age-matched non-pregnant women taking no
medications (N). iPRC was measured as the difference between (tripsin-
activated) total renin and PRC. PRC rose significantly following 2 hours
ambulation both in NP and N women without a significant change in
iPRC (NP: 8.3 to 19.4, P <0.01, N = 13; 4.8 to 13.1, P < 0.001, N =
19; PRC in ngAI/ml/hr; median values, Wilcoxon's test). In a second
study PRC and iPRC were determined before and after 30 minutes
head-up tilt (600) in 15 pnmigravidas and in 10 women with PIH.
Baseline median PRC was reduced in those with PIH but iPRC was not
significantly different (PRC: 9.0 vs. 3.2 ngAI/ml/hr, P <0.01; iPRC: 167
vs. 136 ngAI/ml/hr, NS; NP vs. PIll, Mann-Whitney test). Following
head-up tilt, PRC increased by a median of 5.5 ngAI/ml/hr in NP (P <
0.001) and 2.2 ngAI/ml/hr in PIH (P < 0.05) without a significant change
in iPRC. These increments were not significantly different. These
studies demonstrate that: (i) active renin is secreted following ambula-
tion and upright posture in normal pregnancy as in non-pregnant women
and (ii) women with PIH are able to stimulate active renin to the same
degree as normotensive primigravidas. Therefore, the reduced active
PRC in women with NH appears to represent a premature resetting of
baseline renin secretion back towards non-pregnant levels.
High dietary salt ameliorates the renoprotection of ACE inhibition in
diabetic nephropathy in the SHR. B. Jackson, B. Fabris, D. Paxton,
R.B. Cubella, C.I. Johnson, Department of Medicine, Universitsy of
Melbourne, Austin Hospital, Heidelberg, Victoria 3084, Australia. To
dissociate the effects of ACE inhibition per Se, and a reduction in systemic
blood pressure on the evolution of diabetic renal injury, we have studied
the effects of chronic ramapril treatment in streptozotocin diabetic spon-
taneously hypertensive rats (SHR) with modulation of the hypotensive
effect by a high salt diet. Three weeks following uninephrectomy and
diabetes induction, forty-two SHR rats were allocated to three groups.
Group 1 and 2 received 1% NaCI and group 3 water as drinking solution.
Group 2 and 3 received 0.4 mg/kg/day ramapril over the subsequent 2
month study. One percent NaC1 completely prevented any systemic
hypotensive effect of ramapril. Blood pressure (mm Hg) at 2 months was
241 10 and 246 5 compared with group 3, 162 3 (P <0.001). Plasma
ACE and renal ACE were, however, similarly inhibited in both treatment
groups. Glomerular filtration rate was similar in all 3 groups. Urinary
protein progressively increased in all 3 groups. Urinary protein progres-
sively increased in group I and 2, and was significantly reduced in group 3.
After two months treatment urinary protein (mg/24 hr) was 160 30
(group 1), 240 50 (group 2), and 60 11 (group 3; P < 0.01). ACE
inhibition (systemic and renal) per se was not associated with a reduced
protein excretion in diabetic nephropathy, requiring concomitant control
of systemic blood pressure to become renoprotective.
Experimental diabetic nephropathy: Effects of hyperlipidaemia and
hypertension. S. Panagiotopoulos, D. Vranes, I. Goodall, T. Allen, G.
Jerums, M. Cooper, Endocrine Unit, Department of Medicine, Austin
Hospital, Heidelberg, Victoria, Australia. It has recently been sug-
gested that hyperlipidemia [11 and hypertension [2] may accelerate renal
disorders. Streptozotocin (STZ) diabetes was induced in WKY and
SHR rats (8 weeks old) with sham-injected animals serving as controls.
Control and diabetic (D) animals were randomized to receive either a
normal cholesterol (NC) or high cholesterol (HC-rat pellets coated with
4% cholesterol and 1% cholic acid wtlwt) diet. Body weight, systolic
blood pressure (SBP), serum lipids, glucose and HbAlc and 24-hr
urinary albumin excretion (UAE) were measured monthly over a 28
week period (Table, mean SEM are shown at 28 weeks, N = 4 to 10).
SBP
mmHg
Cholesterol Glucose UAE
mgi
24hrmw
WKY-NC
WKY-HC
SHR-NC
SHR-HC
144 3
140 5
208 12
202 4
2.7 0.2
6.8 0.3a
1.9 0.2
4.8 0.4°
8.5 0.4
8.2 0.7
7.9 0.4
7.3 0.3
1.3
4.3
5.3
17.8
D-WKY-NC
D-WKY-HC
D-SHR-NC
D-SHR-HC
154 9
139 3
216 3
201 7
2.2 0.2
11.7 0.9
2.3 0.2
9.0 0.8
29.7 5.2
37.9 2.2
28.9 4.1
25.8 2.7
13.5
12.5
55.3
61.9
a P < 0.01 vs. respective control
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Cholesterol feeding significantly increased cholesterol levels in WKY
and SHR (P < 0.01). Hypertension and diabetes were the major
determinants of urinary albumin excretion (P < 0.001). High cholesterol
feeding significantly increased the rate of rise in albuminuria in control
but not in diabetic WKY and SHR (P < 0.01).
1. Diamond JR and Karnovsky MJ. Kidney mt 32:671—677, 1987
2. Cooper ME, et al J Hypertens 6:1009—1016, 1988
These studies were supported by the Australian Kidney Foundation
The role of apoptosis in the development of renal cortical tubular
atrophy associated with healed experimental renal papillary necrosis.
G.C. Gobe, R.A. Axelsen, Department of Pathology, University of
Queensland Medical School; Princess Alexandra Hospital, Brisbane,
Australia. The cellular events involved in atrophy of renal tissue
associated with chronic analgesic nephropathy (AN) have not been fully
documented, despite the clinical significance of the lesion. We have
previously shown that a morphologically distinct form of cell death,
termed apoptosis, is involved in the pathogenesis of tubular atrophy in
various other renal diseases. In the present study, renal papillary
necrosis (RPN) was induced in rats using a single injection of bromo-
ethylamine-2-hydrobromide, 250 mg/kg body weight. Rats that devel-
oped RPN of all papillary structures (total RPN) were studied after 2
weeks, 1, 2, 3 and 4 months. Light and electron microscopy, and
autoradiography, were used to detail some of the cellular events
occurring in cortical atrophy that developed as a consequence of total
RPN, Renal weight (R) from treated and control animals were
compared. Although mean R from treated rats did not differ signifi-
cantly from controls (P < 0.5), it was obvious macroscopically and
microscopically that atrophy had occurred. This change was usually
segmental, with only one instance of coherent atrophy. Compensatory
growth of the healthy cortical tissue of affected kidneys, made up of
cellular hypertrophy and hyperplasia, probably accounted for the lack
of change in R. Cortical atrophy developed in the absence of cellular
necrosis, infarction and scarring, and the appropriateness of descrip-
tions of "scarring" in chronic AN is therefore questioned. Atrophic
tubules instead exhibited apoptosis. Intraepithelial macrophages were
involved in the phagocytosis of apoptotic bodies, which were often
subsequently transformed into lipofuscin pigment in the macrophage
lysosomes. We conclude that apoptosis plays a major role in the
development of cortical atrophy in this model of chronic AN.
The relationship of lnffitrating interstitial IL-2R+ mononuclear cells
(MNC) to decreased renal function in human crescentic glomerulonephri-
tis (CGN). H.L. Li, W.W. Hancock, J.P. Dowling, R.C. Atkins,
Departments of Nephrology and Anatomical Pathology, Prince Hen-
iy's Hospital, Melbourne Victoria, Australia. In previous studies of
proliferative ON, we showed that a correlation between interstitial
MNC and decreased renal function, though the significance of such
MNC infiltrates was unknown, IL-2 receptor (IL-2R) expression is a
cardinal feature of cellular immune activation. Using anti-IL-2R mono-
clonal antibodies, we evaluated MNC infiltrates in interstitia of biopsies
from patients with CON (N = 19), IgA disease with crescents (N = 9),
other proliferative ON with crescents (N = 6) and normal kidneys (N =
10). Biopsies were subclassified based on active (cells, fibrin) (N = 15)
or inactive (sclerosed) crescents (N = 19). Biopsies from inactive
crescents had a 7-fold increase in interstitial MNC (total leucocytes 813
89/mm2 MEAN SEM vs. normal 101 16/mm2, P < 0.01, due to T
cells (386 39, P < 0.01) and monocytes (460 50/mm2, P < 0.01) vs.
normals) and included 22% IL-2R+ MNC (178 23/mm2, P < 0.01 vs.
normals). This pattern was further emphasised in active crescents,
when total leucocytes were 1194 78/mm2, (P < 0.01 vs. normals or
inactive) due to monocytes (631 58/mm2, P < 0.05 vs. normals or
inactive crescents). In addition, biopsies with active crescents con-
tained even more IL-2R+ MNC (28%) (330 50/mm2, P < 0.01) than
those with inactive crescents. The numbers of interstitial total leuco-
cytes (P < 0.01), monocytes (P < 0,05), T cells (P < 0.001) and IL-2R+(P < 0.01) were all correlated with raised serum creatinine, and
decreased creatinine clearance. Given the central role of IL-2 in T cell
activation, and the close regulation of MNC IL-2R expression, these
studies suggest interstitial cellular immune activation is involved in the
immunopathogenesis of CGN, regardless of etiology, and particularly
during active crescent formation.
Analysis of renal endothelial cell molecules involved in interactions with
the extracellular matrix and basement membrane. R.J. Faull, G.R. Russ,
Renal Unit, The Queen Elizabeth Hospital, Woodville, SA 5011,
Australia. Endothelial cells (EC) interact with extracellular matrix
(ECM) and basement membrane (BM) proteins via receptors on their
cell surface. The receptors for fibronectin, collagen, and laminin belong
to a family of 6 heterodimers known as very late antigens (VLA)
whereas the receptor for vitronectin is a distinct 134:115 kD het-
erodimer. We have made a monoclonal antibody (QE.2E5) that recog-
nizes the common beta-chain of the VLA family, and have used this and
antibodies obtained from other investigators to analyze: 1) the expres-
sion of these receptors on kidneys, 2) their structure using cultured
human umbilical vein EC, and 3) their function by inhibition of spread
and growth of EC on purified ECM proteins. Comparative immunopre-
cipitation studies with QE.2E5 and another anti-beta-chain antibody
show the existence of several closely related beta-chains on EC. The
EC expresssion of the alpha-chains of VLA-2, -5, and -6 is confirmed in
these experiments. Our studies show that the VLA-6 alpha-chain on
cultured EC is also complexed with a non-VLA-beta-chain which
probably represents the recently described 150 kD beta-chain present
on several epithelial cell lines. In functional assays an anti-VLA-2
antibody blocks the adhesion of EC to purified collagen, demonstrating
that VLA-2 is the EC collagen receptor. VLA-5 has been previously
identified as the fibronectin receptor. VLA-6 is the receptor for laminin
on platelets, but it is unclear whether it has this function in cultured EC
as our experiments show that EC adhere poorly to purified laminin. The
EC fibronectin and vitronectin receptors mediate the EC interactions
with these proteins in the plasma and the ECM. As BM is mainly
composed of collagen and laminin, the study of these receptors gives
insights into the interaction between EC and their adjacent BM.
Involvement of intra-renally generated angiotensin II (Ang II) in
glomerular Ang II receptor expression. V. Timmermans, J.A. Charles-
worth, G.J. Macdonald, P. W. Peake, Department of Nephrology,
Prince Henry Hospital and University of New South Wales, NSW 2036,
Australia. The role of intra-renally generated angiotensin II (Ang II) in
the regulation of mesangial Ang II receptor (Ang II-R) was studied in a
model of nephrotoxic 'nephritis in the rat. Prior experiments had shown
impaired responsiveness of Ang II-R to variation in plasma Ang II
concentration. Intra-glomerular renin was measured on glomerular
homogenates (i.e. by the generation of angiotensin I from rat ream
substrate) and mesangial Ang II-R was examined by Scatchard analysis.
Both parameters were quantitated at 16 hours and 3, 14, 28, 42 and 56
days after the induction of glomerulonephritis by the intravenous
injection of nephro-toxic antibody. Preliminary studies showed that
glomerular renin concentration (GRC) responded appropriately to
changes in sodium intake: glomeruli isolated from chronically sodium
depleted rats contained significantly more renin than controls (25.7
1.4 vs. 18.1 0.7 g AI/hr/l04 glomeruli [mean 5EM], P < 0.001)
while the mean GRC in chronically sodium loaded rats was less than the
control value (15.9 1.1 sg AI/hr/104 glomeruli; NS). There was a
significant inverse relationship between GRC and Ang II-R density in
these control animals r = 0.55, P < 0.05). The relationship between
receptor density and GRC at each time period following injection of
nephrotoxic antibody did not vary significantly from the range estab-
lished in control animals. These data suggest that the intra-renal, rather
than plasma-derived component of the renin angiotensin system has a
significant regulatory influence on mesangial Ang II-R expression in
immunologically-induced glomerular injury.
Pathology of the glomerulus associated with placental ischaemia in a
baboon model of preeclampsia. AG. Gillin, A.F. Phippard, D.M.
Painter, J.S. Horvath, G.G. Duggin, D.J. Tiller, Departments of Renal
Medicine and Anatomical Pathology, Royal Prince Alfred Hospital,
Camperdown, NSW 2050, Australia. Experimental induction of placen-
tal ischemia in the pregnant baboon is complicated by disturbances that
are characteristic of human preeclampsia. These include increased
blood pressure, proteinuria and hypoalbuminemia. Thrombocytopenia
is also found in some animals. These abnormalities resolve rapidly after
delivery by cesarean section. At this time the placenta is also retrieved
intact for confirmation that trophoblastic ischemia has been achieved.
By performing an open wedge biopsy of the kidney at cesarean section,
it has been possible to asses this model for the presence of renal
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histological changes seen in preeclampsia. Further wedge biopsy was
performed at 3 months post-partum for comparison. During pregnancy,
light microscopic examination showed the characteristic glomerular
lesions of preeclampsia, described as 'endotheliosis". The essential
elements are complete or partial obliteration of the glomerular capillary
lumina by expansion of the capillary wall. This obliteration was shown
by the Martius Scarlet Blue stain to be due at least in part to
subendothelial fibrin deposition. The resultant tuft swelling was also
associated with pouting of the glomerular loops into the proximal
tubule. There were no inflammatory or infiltrative lesions, nor areas of
glomerular sclerosis or necrosis. The above changes had resolved in the
subsequent (3 month post-partum) biopsy material. Demonstration of
characteristic renal pathology in this pregnant primate preparation adds
substantial weight to the argument that intervillous hypoperfusion
causes preeclampsia. Further studies of this lesion in the kidney of
baboons, including immunofluorescence and electron microscopy, may
establish more clearly the relationship between the observed glomerular
changes and those found in hypertensive human pregnancy.
Effects of hypoxia on some kinetic and morphological characteristics of
dog kidney epithelial (MDCK) cells, and rat renal parenchymal tubule
cultures. J. Allen, R.A. Axelsen, C. Winterford, G.C. Gobé, Depart-
ments of Pathology, University of Queensland Medical School and
Princess Alexandria Hospital, Brisbane, Australia. Results of an ex-
periment, using an in vivo rodent model of ischemic renal atrophy, have
shown that apoptosis plays an important role in its development.
Apoptosis is a distinctive form of cell death, and it, rather than necrosis,
accounts for cell loss in many instances of tissue atrophy. The present
study constituted an in vitro model of this experiment, to study the
modes of cell death involved after hypoxic treatment of renal epithe-
hum. Madin-Derby canine kidney (MDCK) epithelial cells or cultures of
tubule fragments from rat renal cortex were grown in supplemented
RPMI 1640 medium. The tubule fragments formed groups surrounded
by a single layer of cells, subsequently termed "tubule clusters".
Cultures were either grown in a "physiological" atmosphere of 5% 02,
5% CO2 and 90% N2, or grown in this, followed by a final incubation in
a hypoxic atmosphere of 5% CO2 and 95% N2, for up to 48 hr. Control
and treated cultures were collected immediately prior to hypoxic
treatment, and at 24 hr and 48 hr, for histological and ultrastructural
examination. Both apoptosis and necrosis were observed at signifi-
cantly increased levels (P < 0.05) by 48 hr of hypoxia in the MDCK
cultures. These results were in accord with those from early stages of
the in vivo model. In the control tubule clusters; however, while the
surrounding cells remained normal, the tubular epithelial cells in the
center of the clusters died by apoptosis, possibly as a result of mild
oxygen and/or nutrient depletion. This finding supported the results of
the in vivo model in its later stages. With the added hypoxic stress, the
entire tubule cluster became necrotic. These latter results support
observations of necrosis after severe hypoxia by others. The in vitro
model is thus useful in supplementing in vivo ischemia studies.
The release of vascular heparan sulphate in early stage renal failure
associated with partial ischemia. P. Vassiliou, M. Tay, W.D. Comper,
Department of Biochemistry, Monash University, Clayton, Victoria
3168, Australia. This study is associated with investigating the status of
vascular heparan sulphate in early stage renal failure caused by partial
ischemia in the isolated perfused kidney (IPK). The partial ischemia in
the IPK is characterized by glomerular proteinuria and specific changes
in renal metabolism that would indicate that the perfusion leads to
oxygen radical production. Investigations on vascular heparan sulphate
in this system have been performed by [35S]sulphate incorporation into
macromolecular material by an intrapentoneal injection of the isotope 4
hr prior to kidney isolation. Under these conditions we have demon-
strated that the major amount of [35S]labelled macromolecular glomer-
ular material is heparan sulphate as determined by digestions with
papain, chrondroitinase ABC and HNO2. During perfusion of the
[35SIlabelled kidney, [35S]heparan sulphate is released predominantly
into the perfusate, whereas small amounts were detected in the urine
and lymph. The release of [35S]heparan sulphate was also demonstrated
in isolated glomeruli from perfused kidneys. The release was specifi-
cally perfusion-induced as determined by in vivo cold chase experi-
ments. The released material represented degraded heparan sulphate
proteoglycan which was mainly derived from the whole renal vascula-
ture. The release of glomerular [35S]heparan sulphate could be inhibited
completely by the inclusion of an oxygen radical scavenger mixture in
the perfusate. The same mixture also substantially reduced glomerular
proteinuria. The conclusion from these studies is that early-stage renal
failure in partial ischemia involves oxygen free radical-mediated dam-
age to renal capillaries, specifically to heparan sulphate proteoglycan,
which leads to glomerular proteinuria.
Pedicel alterations and glomerular reactions in relation to proteinuria.
J.P. Dowling, N.M. Thomson, R.C. Atkins, Department of Tissue
Pathology and Nephrology, Prince Henry's Hospital, Monash Medical
Centre, Melbourne, Victoria, Australia. There is some correlation
between the extention of pedicel effacement and the quantity of protein
excreted by the kidney in patients in whom other glomerulonephritic
causes of proteinuria hematuria can be excluded by biopsy. To
determine the relation between proteinuria, subsequent clinical out-
come and the findings of no proliferation, mesangial proliferation,
segmental sclerosis, whether peripheral or perihilar, and focal global
sclerosis, we analyzed biopsies from 63 patients aged 2-73 years. A
spectrum of glomerular pathologies emerged with outcome not always
predictable from biopsy appearances. In general, favorable findings
were partial pedicel effacement or complete effacement without prolif-
eration (minimal change lesion), and a peripheral/"tip" segmental
sclerotic lesion. A variable outcome was found with complete efface-
ment and perihilar segmental sclerosis and/or mesangial proliferation.
The binding of 'nephritis-strain associated protein (NSAP) to the
human glomerulus. P. W. Peake, J.A. Charlesworth, T. Karplus, B.A.
Pussell, Department of Nephrology, Prince Henry Hospital and Uni-
versity of New South Wales, NSW 2036, Australia. 'Nephritis-stain
associated protein (NSAP) was isolated from the supernatant of Strep-
tococcus pyogenes (Group A) cells grown in culture, radiolabelled and
its binding to purified human glomeruli compared with that of another
(Group C) streptokinase, native human albumin and cationized human
albumin. The affinity constants (Ka) for the interactions between
glomeruli and NSAP, streptokinase, and highly cationized albumin
were 4.0 2.4 x lO M, 7.3 4.1 x 106 M and 6.0 0.4 x io M,
respectively (mean SEM). The site number per glomerulus for each
was 6.8 3.3 X 106, 3.2 1.6 X io and 6.2 0.002 X loll,
respectively. Under the incubation conditions, no specific binding was
detected for native or partially (P = 7.6-9) cationized human albumin.
An excess of unlabelled NSAP inhibited the specific binding of labelled
streptokinase, and unlabelled streptokinase similarly inhibited the spe-
cific binding of NSAP. Experiments using various chemical crosslinking
reagents to identify the binding site for NSAP suggested that it bound to
a large molecule unable to enter low-percentage reducing SDS gels; this
implied a molecular weight >106 D. These data emphasize the differ-
ence in binding characteristics of NSAP compared to other antigens
(either circulating or planted) involved in the mediation of experimental
glomerular injury. The tightness of binding exceeded that of highly
cationized albumin and this property may reflect the potential of NSAP
to initiate pro-inflammatory sequelae, such as complement activation in
situ.
Role of macrophages in glomerular crescent formation in experimental
anti-GBM disease. H. I'. Lan, D.J. Paterson, R.C. Atkins, Department
of Nephrology, Prince Henry's Hospital, Melbourne 3004, Australia.
The histogenesis of glomerular crescents concerning their epithelial or
macrophage origin is still controversial. We examined the composition
of early cellular crescents in two anti-GBM models: accelerated neph-
rotoxic serum nephritis (NTN) in 16 rats (leukocyte populations iden-
tified by immunoperoxidase labelling), and a classical NTN in rabbits
(examined by non-specific esterase (NSE) and electron microscopy). In
the rat model, 5 to 17% of crescents contained no leukocytes. These
epithelial crescents had intact Bowman's capsule (BC) and there was
little periglomerular infiltration. In contrast, 83 to 95% of crescents
contained leukocytes and these displayed a ruptured BC and a heavy
periglomerular infiltrate. Leukocytes made up 54 6% (OX-i ) of
crescent cells, with composition of crescents being: 49 8% EDl
macrophages, 7 4% OX-191 T cells, and 4 2% IL-2R cells. In the
rabbit model, all cellular crescents contained NSE cells (57 5% of
total crescent cells) and partial destruction of the BC was evident in all
cases using silver staining. Electron microscopy confirmed the BC
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damage and identified the presence of macrophages, lymphocytes,
neutrophils and some fibroblasts in the crescents while epithelial cells
were only evident in parts of crescents where the BC was intact. This
study supports the argument that macrophages are a major component
of crescents and indeed suggests that they are responsible for destruc-
tion of the BC that enables fibroblast influx. The small, but significant,
number of activated mononuclear (IL-2Ri cells found in the crescents
may directly participate in the damage process.
Lymph drainage in experimental anti-GBM glomerulonephritis (GN) in
the rat. H. Y. Lan, D.J. Paterson, R.C. Atkins, Department of Nephrol-
ogy, Prince Henry's Hospital, Melbourne 3004, Australia. Interstitial
leukocyte infiltration is a feature of most forms of GN, but trafficking of
these cells from the kidney has received little attention. We addressed
this issue in anti-GBM disease in primed rats using immuno-peroxidase
labelling to identify leukocyte populations. Days 0.5, 1, 2, 3, 7, 14, 21
and 28 after nephrotoxic serum injection were studied. The main
findings were: (1) interstitial leukocyte infiltration was restricted to
periglomerular areas for the first 3 days, spread through the entire
cortex to the cortico-medulla junction by day 7, and was widespread in
the medulla by day 14. (2) In the marginal sinus of the draining kidney
lymph node (KLN) a significant increase in OX-i9 T cells was
apparent over days 1-2 (33-43 +ve cells/lOO sinus cells cf. 22/100 cells in
control). An increase in EDl macrophages was seen at day 3 (40
cellsIlOO cf. 2 to 4 cells/lOO in normal) in association with marked sinus
dilation. Macrophage influx peaked at days 7 to 14 (69 to 74 cells/l00)
and this influx correlated (P < 0.001) with the interstitial macrophage
infiltration. (3) Germinal centers of the KLN were enlarged with a
significant increase in T cells over days 7 to 14 (8 to 21% of total cells
cf. ito 8% cells in control). Significant increases in EDI + macrophages
were found in both germinal centers and the paracortex over days 7 to
21 (P < 0.05). Antigen (rabbit IgG) was detected in the germinal centers
from day 3 onwards. These results indicate that not only T cells of the
inflammatory renal infiltrate drain to the KLN and interact with B cells,
but that there is a flow of inflammatory macrophages through the cortex
and medulla to the KLN where they may be involved in antigen
presentation.
The effects of deoxyspergualin on anti-GBM nephritis in rats. P.G.
Kerr, H.Y. Lan, R.C. Atkins, Department of Nephrology, Prince
Henry's Hospital, Melbourne 3004, Australia, Deoxyspergualin
(DOSP) is a new immunosuppressant developed in Japan; its mode of
action is poorly understood. DOSP has been reported to modify the
course of spontaneous lupus-like glomerular lesions in susceptible
mice. We have induced anti-GBM nephritis in rats using rabbit neph-
rotoxic serum and attempted to modify it with DOSP. By 14 days this
resulted in a mild glomerulonephritis histologically with moderate
proteinuria and hematuria. Half the experimental animals were treated
with DOSP 2.5 mglkg/day i.p. from the day of injection of nephrotoxic
serum. Rats were sacrificed on days 3 and 14 (N = 5 in each
experimental group). At day 3 there were no significant changes in
serum Cr or urea, protein excretion, Car, or immunohistology of the
kidneys when the treated animals were compared to controls. At day
14, there was improvement in the immunohistological appearance of the
kidneys with a decrease in the total number of intraglornerular leuco-
cytes in the DOSP group (5.94 1.04 untreated vs. 3.06 0.78 treated,
P < 0.01). T cell and macrophage numbers were similarly decreased.
There was also a decrease in the amount of urinary blood present on
hemastix (+ +-+ + + vs. neg-trace), however there were no significant
improvements in serum Cr or urea, nor in urinary protein excretion. We
conclude that in this time frame, DOSP has only minimal benefit in
reducing the glomerular damage of rat nephrotoxic nephritis, even
though the glomerular and interstitial leucocytic infiltration was re-
duced.
IL-2R Mononuclear cell (MNC) composition of crescents in human
crescentic gloinerulonephritis (CGN). H.L. Li, W. W. Hancock, J.P.
Dowling, R.C. Atkins, Department of Nephrology and Anatomical
Pathology, Prince Henry's Hospital, Melbourne 3004, Australia. We
previously established macrophages are a major component of cellular
crescents during active CGN, though the basis and significance of such
accumulation is unclear. Using anti-IL-2R and other monoclonal anti-
bodies, we examined biopsies showing >60% crescents (N = 19), IgA
disease with crescents (N = 9) and other proliferative GN (N = 6).
Total cells and labelled cells within each crescent were counted, and
results grouped into biopsies with active (cells, fibrin) or inactive
(sclerosed) crescents.
Cornposition of crescents % total ccIls mean SEM
IL-
CGN Macro- T 2R+ CD4 CD8
group WBC phages cells cells cells cells
Active 60.5 43.1 7.1 5.0 4.9 2.5(N = 15)
Inactive 19.1 7.2 0_3a 0—2 0—2 0-1
(N = 19)
Ranges are shown when numbers very small
Hence in active but not inactive disease, leucocytes, particularly
mactophages and some T cells, comprise >60% of crescent cells and
8% of leucocytes are IL-2R+. Given the close regulation of IL-2R
expression on activated MNC, this result indicates crescent formation
may result by recruitment of macrophages by sensitised T cells,
analogous to a DTH response, and suggests a direct role for cellular
immunity in human CGN.
Cyclosporin A and host defence in infection. D.J. Orm rod, S. Cawley,
T.E. Miller, Department of Medicine, University of Auckland, Park
Road, Auckland, New Zealand. A significant advance in the manage-
ment of organ graft rejection has been the introduction of cyclosporin A
(CsA; SANDIMMUN). CsA specifically targets T-lymphocytes and a
decrease in the incidence of opportunistic infections would therefore
have been expected, when CsA-treated patients are compared with
those given less specific immunosuppressive agents. No real difference
has been observed and it is likely that CsA affects components of
cellular and/or inflammatory host defence mechanisms other than CMI.
Our earlier work showed that T-lymphocytes were not involved in the
host response to experimentally induced pyelonephritis. The model
therefore provided an ideal probe to evaluate the potential of CsA to
modulate host defences other than CMI. When CsA was administered
to rats with pyelonephritis, the infection was exacerbated. The finding
that circulating WBC numbers were not depressed suggested that CsA
produced qualtitative rather than quantitative changes in leucocyte
funciton. Parallel experiments identified the neutrophil as the key cell in
the host response to renal infection and the effect of CsA on neutrophil
function was therefore investigated in detail. CsA administration did
not affect the in vitro metabolic activity of neutrophils, nor their
potential to phagocytose and kill microorganisms. However, the in vivo
ability of neutrophils to mobilize to a sterile inflammatory foci was
significantly impaired. Further experiments, using models of pyelone-
phritis and subcutaneous infection, demonstrated that the CsA-induced
suppression of neutrophil mobilization was directly related to the
observed increase in bacterial numbers and exacerbation of tissue
damage. These results provide strong evidence that CsA modifies the
acute inflammatory response through non-T-lymphocyte related mech-
anisms. This may explain the pattern of infection in transplant recipi-
ents treated with CsA and could also account for the efficacy of CsA in
conditions where an inflammatory response is associated with the
natural history of the disease.
Immunomodulation of experimental tubulo4nterstitial nephritls (TIN).
KM. Bannister, A. D'Angelo, Renal Unit, Royal Adelaide Hospital,
North Terrace, Adelaide, SA 5000, Australia. Immunization of the
Lewis (LEW) rat with homologous renal basement membrane and
adjuvants (complete Freund's and B. pertussis) results in the develop-
ment in 14 to 21 days of an autoimmune TIN characterized by T cell
infiltrates but not kidney fixed antibody, a picture analogous to human
TIN. In the present study immune modulation of the LEW TIN was
attempted by: 1) induction of suppressor mechanisms using either a)
low dose cyclophosphamide (CTX) (2 mg/kg i.p.) from the time of
immunization or b) pre-immunization with immunogen plus incomplete
Freund's adjuvant for 21 days prior to routine challenge. 2) Drug
modulation of IL-2 response using a) high (12 mg/kg) or low (1 mg/kg)
dose gold i.p. from the time of immunization; b) cyclosporin A (CsA) (6
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mg/kg) given either daily post-immunization or from day 14 only.
Animals were sacrificed at day 21 for histological examination and for
harvesting of splenic T cells. T cell IL-2 responses were assayed using
a mouse splenocyte blast proliferation assay and LL-2 receptor expres-
sion by FACS analysis with rat monoclonal 0X39. Neither CTX nor
gold (high or low dose) altered LEW TIN histologically compared to
controls. In rats pre-vaccinated or treated with CsA from Day 14 the
extent of disease was partially reduced but only CsA daily completely
prevented development of histological TIN. T cell IL-2 response to Con
A or non-renal recall antigen (PPD) and IL-2 receptor expression in the
latter group were no different to controls. The response to autologous
renal antigens is currently being evaluated. We conclude that CsA in
contrast to other potential immune modulators, if started early, can
effectively alter the course of LEW TIN.
Experimental Goodpasture's syndrome in the rat induced by anti-lung
antibody. T.J. Neale, N. W. Boyce, N.S. Fernando, S.R. Holdsworth,
Wellington School of Medicine, Wellington, New Zealand, and Prince
Henry's Hospital, Melbourne 3004, Australia. Studies of experimental
anti-basement membrane (BM) antibody-induced disease have been
restricted mainly to anti-glomerular models. In the current work, acute
pulmonary and renal injury was established in rats using a sheep
antibody against rat lung antigen. Protein permeability increased in both
organs following the binding of antibody to BM antigens [Lung perme-
ability index (LPI) 0.342 0.009 vs. control 0.214 0.011, P < 0.05.
Urinary protein excretion 5.112 0.899 mg/hr vs. control 0.402 0.008
mg/hr, P < 0.01]. The lung injury threshold was 27.2 4.8 g antibody
globulin per gram. Immunoblot analysis with the anti-lung antibody
indicated a major common antigenic determinant (82 to 84 kD) within
collagenase-solubilized pulmonary and glomerular BMs. Immunogold
electron microscopy revealed, in intense linear patterns, BM binding
sites for antibody within alveoli and glomeruli. Functional lung injury
was prevented by either leucocyte or complement depletion (LIP
antibody-treated, leucocyte-depleted rats 0.219 0.024; LPI antibody-
treated, complement-depleted rats 0.235 0.034; both P > 0.05
compared to controls). Mediation of lung injury in this acute model of
Goodpasture's syndrome is both complement and leucocyte-depen-
dent, as previously described for heterologous anti-glomerular BM
antibody-induced disease.
IL-i and TNF depress glomerular endothelial thrombomodulin (TM)
expression in vitro and in vivo. W. W. Hancock, Department of Nephrol-
ogy, Prince Henry's Hospital, Melbourne Victoria 3004, Australia. In
vitro, IL-I and TNF modulate some important properties of human
umbilical vein endothelial cells (HUVEC): they induce leucocyte adhe-
sion molecules (e.g. ELAM-l), and upregulate procoagulant and down-
regulate endothelial TM anticoagulant activities. We have shown that as
with HUVEC, IL-I induces ELAM-l and tissue factor on human
glomerular endothelial cells in vitro. We now analyzed by immunoper-
oxidase the in vivo and in vitro effects of IL-I and TNF on the
biologically critical TM-based anticoagulant pathway. Rabbits were
injected with IL-I (50 U/kg), TNF (100 ng/ml), or saline alone via the
renal artery and sacrificed 6 to 12 hours later. Normal rabbit glomeruli
were isolated by sieving and cultured with IL-I (10 U/mI) or TNF (20
ng/ml), with or without neutralizing anti-cytokine antibodies. Lastly,
kidneys were collected from rabbits during the autologous phase of
nephrotoxic nephritis (NTN). Sections of normal rabbit kidneys
showed crisp intertubular capillary and glomerular endothelial labeling
for TM, as did kidneys from rabbits receiving saline alone, and an
absence of fibrin. However, after 8 hours, kidneys in rabbits injected
with IL-i or TNF essentially lacked demonstrable TM, and showed
extensive glomerular deposits of fibrin. Moreover, by 8 hours in vitro,
IL-I and TNF abolished endothelial TM expression by isolated glomer-
uli. Similarly, by 24 hours post-injection of anti-GBM antibody, rabbit
glomeruli lacked TM and showed progressive fibnn deposition, unlike
controls injected with normal serum. These studies show IL-I and TNF
have potent effects on glomerular TM expression, and suggest depres-
sion of this anticoagulant pathway is involved in the fibrin deposition of
NTN and potentially other forms of glomerulonephritis involving cy-
tokine generation.
The nephrotic syndrome: Role of cytokines? M.G. Suranyi, C. Quiza,
A. Guasch, I.. Newton, B.D. Myers, B.M. Hall, Division of Nephrol-
ogy, Stanford University Medical Center, Stanford, California 94305-
5114 USA. The plasma and urinary levels of five discrete cytokines
were measured in thirty patients with nephrotic syndrome undergoing a
course of therapy with cyclosporine (CsA) and thirty normals, to
investigate a possible role for cytokines as mediators of glomerular
barrier dysfunction in the nephrotic syndrome. Patients with biopsy
proven MCGN, FSGN and Membranous GN were studied before,
during and after a therapeutic trial of CSA. Levels of IL-1f3, IL-2,
TNFa, IFN7 and IFNa were assessed in plasma and urine with the use
of Medgenix RIA kits. Levels of IL-l/3, IL-2, IFNyand IFNa were not
different in normals and untreated nephrotics, but plasma TNFa was
elevated in nephrotics (11.85 pg/mI 12.93 SD vs. 3.24 2.92, P <
0.0002), particularly in Membranous GN, and to a lesser extent in
FSGN. This elevation did not correlate with renal function, degree of
proteinuria or fractional clearance of albumin. Only plasma TFNa
showed a reduction in patients receiving CSA, but levels rose shortly
after cessation of CSA, even though remission often persisted. Maximal
reduction in TNFa was found in FSGN and to a lesser extent in
Membranous GN. Neither pre-CsA nor on-CsA levels of TNF pre-
dicted response to therapy. Fractional clearance of no cytokine differed
from normals, suggesting that TNFa was not added to urine at the level
of the glomerulus. Mitogen stimulation of peripheral mononuclear cells
with PHA and Con A showed an increased proliferative response in
nephrotics to PHA but not Con A, and increased levels of TNFa, IL-l/3
and IFNo in PHA and Con A culture supernatants. The finding of
elevated plasma and culture supernatant levels of these macrophage
derived cytokines (TNFa, IL-1f3, IFNa) rather than T cell-derived
cytokines may be important in our understanding of these disorders.
Augmented glomerular procoagulant activity (PCA) is associated with
glomerular T lymphocyte infiltration in experimental anti-GBM glomer-
ulonephritis (GN). P.G. Tipping, M.G. Lowe, S.R. Holdsworth, Mo-
nash University, Department of Medicine, Prince Henry's Hospital,
Melbourne, Victoria 3004, Australia. Augmentation of macrophage
(mØ) PCA is a sensitive index of cell mediated immunity. Macrophage
dependent augmentation of glomerular PCA is seen in experimental
anti-GBM GN in rabbits, and is associated with the initiation of
glomerular fibrin deposition. Recently, glomerular T lymphocyte infil-
tration has been demonstrated in active autologous phase anti-GBM
GN, but not when autologous phase anti-GBM GN was induced
passively. The glomerular PCA expression in these two models was
compared to assess potential for T cells to induce MØ PCA expression
in anti-GBM GN. in active autologous phase GN, T cells were maximal
on day 5, and mØ's peaked on day 6 (68.6 17.9 mØ/glom, normal 0.3
0.2 mØ/glom). Glomerular PCA at this time (day 6) was 397 63
mU/l03 glom (normal, 30.7 10.5 mU/l03 glom); i.e. 5.3 mU of PCA
per l0 mØ's. In passive disease, a significant glomerular influx of T
cells was not seen. Glomerular mØ numbers were 59.9 13.0 m$/glom,
and glomerular PCA was 171 48 mU/103 gloms; i.e. 2.3 mU of PCA
per l0 mØ's. Therefore, in these two models of anti-GBM GN,
glomerular T cell infiltration is associated with augmented glomerular
PCA expression. These studies support a role for T cells in mØ
activation and augmentation of glomerular PCA. They suggest the
involvement of cell mediated immunity in the development of glomer-
ular injury in active autologous phase anti-GBM GN.
The effects of deoxyspergualin on human cytotoxic T lymphocytes
(CTL), NK cells and LAK cells. P.G. Kerr, R.C. Atkins, Department of
Nephrology, Prince Henry's Hospital, Melbourne, Victoria 3004, Aus-
tralia. Deoxyspergualin (DOSP) is a new immunosuppressant with
proven efficacy in experimental transplantation. Unlike cyclosporine, it
is also useful in the treatment of acute rejection, Because of this we
have examined the effects of DOSP on the induction and activity of
CTL. We have also examined its effects on other aspects of cellular
cytotoxicity—namely NK cell killing and LAK cell killing. To generate
CTL, human PBL were exposed to mitomycin-C treated Raji cells (a
human B cell line that expresses HLA-DR) for 7 days. Cytotoxicity was
assessed using fresh 51Cr-labelled Raji cells. DOSP was able to inhibit
the induction of CTL when present from the initiation of the culture in
a concentration dependent manner. At a 30:1 effector target ratio the %
killing was 0 DOSP 57%, 1 sg/ml DOSP 42% (P < 0.05), 10 zg/ml DOSP
2.6% (P < 0.01), and 100 g/ml DOSP 0% (P < 0.01). This killing was
demonstrated to be antigen specific by blocking with Class I MAb.
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When added on day 6 of a 7 day culture period at a concentration of 100
g/m1 DOSP inhibited CTL activity significantly; at 30:1 ET ratio: 0
DOSP 57% vs. 100 g/ml DOSP 13.1% (P < 0.05). DOSP had no
significant effects on NK cell killing of the K562 cell line nor any effects
on LAK cell killing of the NK resistant Daudi cell line over an 18 hour
period. (LAK cells were generated by culture of human non-adherent
PBL with 100 p/mI rhIL-2). Thus DOSP was capable of inhibiting the
induction of CTL and of inhibiting the activity of CTL generated after
alloantigenic stimulation. However, it has no significant effects on
NK-cell or LAK-cell killing. The ability of DOSP to reverse acute
rejection episodes may relate to this capacity to inhibit generated CTL.
Dialyzer reprocessing with Renalin. S. Fleming, K. Foreman, K.
Shanley, R. Mihrshahi, V. Siskind, Departments of Renal Medicine,
Royal Brisbane Hospital, Herston 4029 and Social & Preventive
Medicine, The University of Queensland, Australia. Despite theoretical
cost savings from reuse and the superior biological properties of used
dialyzers, the ASN and AKF have recently expressed misgivings about
dialyzer reprocessing; it is not practised widely in Australia. In a 6
month prospective study of 2759 dialyses performed on 59 patients we
evaluated the impact of introducing automated dialyzer reprocessing
using the peracetic acid-based sterilant, Renalin. Dialyzers were with-
drawn from service after a maximum of six uses. The average number
of uses achieved with each dialyzer was 4.5. There were significant
differences between survival among the different types of dialyzers
employed (P < 0.001). Dialyzer survival was unaffected by the dialysate
base. The most common reason for discarding dialyzers prematurely
was failure of the volume test. In vivo clearances of urea, creatinine and
phosphate (in 33 patients) were not altered by reuse but there was a
decrease in ultrafiltraation characteristics (in 8 patients) from a mean of
3.3 to 3.1 mI/hr/mm Hg (P < 0.05). No significant adverse event was
attributable to reuse. Mean nadir systolic and diastolic BPs during
treatment with used dialyzers (114.3 and 61.3 mm Hg) were significantly
higher than for new dialyzers (111.4 and 59.5 mm Hg; P < 0.001).
Patients experienced significantly fewer symptoms with reused dialyz-
ers (P < 0.001). Savings of over $25,000 were achieved through reuse.
Nursing concerns about possible ill effects of Renalin expressed prior to
the study were significantly reduced after 6 months. Dialyzer repro-
cessing can be safe, efficacious, cost effective and produce significant
patient benefits.
Streptokinase-induced peritonitis syndrome. B.J. Nankivell, N. Lake,
A. Gillies, Departments of Nephrology, Royal Newcastle and West-
mead Hospitals, NSW, Australia. Intracatheter streptokinase (SK) is
advocated as a safe and effective treatment for recurrent bacterial
peritonitis and catheter fibrin blockage in chronic ambulatory peritoneal
dialysis (CAPD) patients. Thirty-five instillations (21 catheters, 20
patients) were reviewed. Streptokinase 750,000 units in 100 mIs normal
saline was instilled and the catheter clamped for 23 hours. SK treatment
was performed during resolution of a peritonitis episode and followed
by 10 days of antibiotic appropriate for the recurring organism. Sixteen
patients received SK for relapsing peritonitis. Treatment was successful
in eight patients, but recurring S. epidermis peritonitis was not effec-
tively treated (P < 0.05). SK was ineffective for catheter malfunction.
Side effects of SK were frequent: fever in 2 1/35 treatments, abdominal
pain in 17/35 treatments. Turbid dialysis effluent was noted in 17
treatments and mildly blood-stained effluent in three. A syndrome of
cloudy bags and fever or abdominal pain occurred in 54% of instilla-
tions. In two instances SK treatment was followed within five days by
fungal peritonitis. SK is effective for recurring bacterial peritonitis
when this is due to organisms other than staph epidermis. SK treatment
may be accompanied by a high number of side effects and by a
peritonitis syndrome presumably due to digestion of bacterial and
inflammatory products from the catheter or peritoneal surface.
Hepatitis C virus infection in hemodialysis patients. S.D. Roger, E.
Crewe, A. Cunningham, D.C.H. Harris, Renal and Virology Depart-
ments, Westmead Hospital, Westmead, NSW 2145, Australia. Non
A-non B hepatitis (NANBH) accounts for >90% of transfusion-related
hepatitis, and is a rare but important cause of hepatitis and secondary
liver disease in hemodialysis patients. To determine the prevalence of
hepatitis C virus (HCV) exposure (the major cause of NANBH), a cross
sectional study was performed on in-center hemodialysis patients using
an immunoenzyme assay (Ortho Diagnostic Systems) for the detection
of antibody to HCV. Fifty-four patients (32 male) aged 49 15 years (i
SD) and on hemodialysis for 57 49 months were tested, Six of 54
(11%) were HCV antibody positive. All had received blood transfusions
(4 units, N = 1; >10 units, N = 5) and 3 previous renal transplants (I,
2 and 3 grafts, respectively). All denied i.v. drug abuse or homosexu-
ality. Three had a past history of hepatitis and 4 were hepatitis B (HBV)
core antibody and 5 CMV antibody positive. One patient currently has
abnormal ALT & iT. Of the HCV negative patients, Shad never been
transfused, 13 had been transplanted previously and 8 were HBV core
antibody and 39/45 CMV antibody positive. Summary: In this study,
approximately 10% of in-center hemodialysis patients, all of whom had
been previously transfused, were HCV positive. This is comparable to
reported prevalence rates in Spanish and German hemodialysis pa-
tients.
Reduction in j32-microglobulin (2-m) levels during hemodialysis (lID)
and hemofiltration (HF) with highly permeable membranes. L.P. McMa-
hon, J. Dempster, J.K. Dawborn, Renal Unit, Department of Medicine,
Austin Hospital, Heidelberg, Victoria 3084, Australia. To determine
the most effective means of removing p2-m with the AN69 membrane,
4 stable HD patients were studied for a period of between 24 and 90
weeks, Maneuvres included HD, HF, and alteration of membrane size
(1.0, 1.2 or 1.6 sq.m.), blood flow (Qb, 200 or 350 mI/mm) or filtrate
volume (HF). f32-microglobulin levels were measured pre-, post- and
pre-HD/HF weekly. HF produced a greater fall in both pre- (P 0.00 1)
and post- (P = 0.003) procedure levels of 2-m than HD for the same
membrane size. Falls in 132-m levels associated with HF (24 liter
exchange, 1.6 sq.m.) were sustained in all patients (N = 3) for up to 54
weeks [pre: 31.3 0.41 vs. 47.3 1.7 (cuprophane) mg/liter, SE;
post: 10.9 0.5 vs. 51.3 4.9]. All patients felt better on HF. The 1.6
sq.m. membrane was more effective than the 1.0 sq.m, membrane in
reducing postdialysis 132-m levels (P = 0.04). The smaller membranes
were also less suitable for HF because of the increased procedure time
(60 to 80 minutes). HD (AN69, 1.0 sq.m., N = 4) was less effective than
HF in maintaining reduced predialysis 3-m levels despite evidence of
continued removal by lower postdialysis values (pre: 39.3 1.0; post:
33.2 0.9). In an attempt to enhance 132-m removal during HD, Qb was
increased in one patient after 12 weeks (Qb 220 mI/mm, 1.0 sq.m.) to
350 mI/mm and maintained for a further 12 weeks. Levels of /32-m fell
both pre- (P < 0.001) and post- (P = 0.007) dialysis, however changes
were small compared with HF. We conclude that HF is more effective
than HD in reducing 32-m levels with the AN69 membrane. HF may
also reduce associated symptoms of dialysis related amyloid. Only
minor improvements in f32-m removal are obtained with increasing
efficiency of HD.
Right atrial catheters: Reliable, immediate vascular access. D.J. Good-
man, L.M. FitzGerald, G.J. Becker, P. Kincaid-Smith, D.M.A. Fran-
cis, Departments of Nephrology and Surgery, The Royal Melbourne
Hospital, Victoria 3050, Australia. We have prospectively evaluated
the use of operatively inserted right atrial, double-cuff Teflon catheters
in patients in whom vascular access is required immediately for
prolonged periods (greater than 4 weeks) for plasma exchange or
chronic dialysis. Twenty-three catheters (8 single lumen, 15 double
lumen) were inserted in 22 patients (11 male, 11 female; mean age 44,
range 9 to 71). Seventeen catheters have been removed, 6 catheters
remain in situ. Patients were treated as outpatients if otherwise medi-
cally fit. Plasma exchange was carried out on 89 occasions in 9 patients
through double lumen catheters over periods from 4 to 8 weeks (mean
45 days). Blood flow exceeded 100 mI/mm and the only complication
was 1 catheter infection with bacteremia which responded to intrave-
nous antibiotics and catheter removal. Hemodialysis was carried out on
14 patients for periods ranging from I to 6 months, mean 96 days,
median 4 months. One catheter was replaced at 4 weeks due to
infection. Five deaths occurred, none related to catheters (carcinoma 1,
cardiac 3, peritonitis I). During hemodialysis adequate blood flow (up to
200 to 250 mI/mm) were achieved in all but one dialysis with a single
lumen catheter which subsequently functioned adequately, No catheter
was removed because of thrombosis. The reasons for catheter removal
were infections (5 cases, 4 staphylococci, 1 candida) maturation of
alternative access (4 cases) and successful renal transplantation (1
case). The right atrial catheters provide excellent immediate vascular
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access for plasma exchange or hemodialysis, and are able to be used for
hemodilaysis periods exceeding 6 months if required. The main com-
plication is infection, which responds to antibiotics and catheter re-
moval.
Blood pressure management in home hemodialysis patients. K.L.
Lynn, A.L. Buttimore, R.R. Bailey, R.A. Robson, Department of
Nephrology, Christchurch Hospital, Christchurch, New Zealand.
Many patients on hemodialysis (HD) receive anti-hypertensive medica-
tion despite having volume-dependent blood pressure (BP). In our
experience BP can be controlled in all patients on home HD by
maintenance of dry body weight. Sixty-nine patients (29 women; 40
men), mean age 46 (SD15) years, began training for home HD since
January 1983. Causes of renal failure were: glomerulonephritis (19),
hypertension (12), diabetes (11), reflux nephropathy (7), polycystic
kidneys (7), analgesic nephropathy (3), other (10). Before HD 15
patients had poor BP control and 4 malignant hypertension. All antihy-
pertensives were withdrawn during the first week of HD. Dry body
weight was achieved by appropriate fluid restriction and ultrafiltration.
All patients began home HD (3 x 6 to 10 hr) on no antihypertensives.
After follow-up of 2 to 56 (mean 24) month 39 patients (8 with failed
transplant) remained on home HD, 15 were dead, 12 had a transplant
and 3 were on CAPD. Mean (SD) of last 8 pre-HD BPs at follow-up:
Age (yr) <40 40—49 50—59 60—69 70+
Patients
(N)
BP
Systolic
Diastolic
8
137 (16)
79(15)
9
139 (20)
84(6)
13
141 (27)
79(11)
6
135 (23)
74(12)
3
130 (10)
74(8)
All patients on HD had their BP controlled without anti-hypertensive
medication.
Hemofiltration in intensive care unit acute renal failure (ICU ARF):
Workload, outcome and cost. M.A.B. Thomas, G. Leslie, K-Y, Lee, G.
Clarke, Departments of Nephrology and Intensive Care, Royal Perth
Hospital, Perth, WA 6000, Australia. To determine the effect of the
introduction of hemofiltration/hemodiafiltration (HF/HDF) in 1988 on
the management of intensive care ARF (defined as rise in s. creatinine
>100 smol/liter), prospective data on all ICU admissions for the
preceding 3 years were reviewed. The number of dialysis/filtration-
treated ARF: all ARF: all patients were 44:184:1756 in 1987, 49: 155:
1518 in 1988, and 40: 165: 1430 in 1989 (to November). Total dialysis!
filtration treatment days (no. of patients) treated with PD:HD:HF/HDF
were 140(18):61(15):76(Il) in 1987, 49(l2):19(lO):300(27) in 1988 and
54(5):9(5):233(30) in 1989. The percentage of patients surviving to leave
hospital treated with PD:HD:HF/HDF was 50:40:27% in 1987, 17:50:
52% in 1988, and 20:60:43% in 1989. Illness severity on admission was
equivalent in all groups (APACHE H mean score = 19.2, range = 16 to
22). The cost of HD vs. HDF was estimated for providing I week of
either daily bicarbonate HD (consumables $A 59 + Renal Unit staff $A
84 per HD + machine depreciation) or veno-venous HDF (consumables
$A 413/week + pumps depreciation, no extra stafi) using standard
accounting techniques, and calculated to be $A 1020 per week for HD
and $A 1182 per week for HDF. HF & HDF have gained rapid
acceptance in the management of ICU ARF, have dramatically reduced
the Renal Unit workload, and have equivalent costs to acute HD by
staff savings; no improvement in mortality has yet been seen.
Human recombinant erythropoietin (rHuEPO) stimulates platelet pro-
duction and thrombosis. B.J. Nankivell, J. Koutts, D.C.H. Harris,
Department of Medicine, Westmead Hospital, Westmead, NSW 2154,
Australia. The prothrombotic tendency of rHuEPO therapy is usually
ascribed to the rise in hemoglobin. To assess the possible role of
platelets, 7 hemodialysis patients were intensively studied before and 1,
4 and 8 weeks after commencing rHuEPO. Platelet count rose 16% (+37
x 109/liter plat, max wk 4, P < 0.01) coincident with correction of
bleeding time (BT) in 5/7 (P < 0.05 at 4 wk). Improvement in BT
occurred with individually significant platelet surge (P < 0.05 at 4 wk)
and prior to rise in Hb. Plasma fibronectin fell progressively (192
20%, 115 8%,* 104 8%,* 0,4 & 8 wk; < 0.01), as did platelet
collagen aggregation (46 8%, 15 9%; 5 g/ml; 0 & 8 wk, P < 0.05).
Intraplatelet serotonin rose by 85% (41.9 8.7, 77.8 14.2; 0 & 8 wk,
NS). Plasma fibrinogen, VWF-RAg, proteins C & S. predialysis urea,
other aggregation studies and platelet morphology (transmission EM)
were unchanged. Platelet morphology (activated forms) but no other
test was different in 2 patients with thrombosis of stenosed fistulae.
Cadaveric renal transplant vein thrombosis occurred in another patient
who had received rHuEPO. In conclusion, the prothrombotic tendency
of rHuEPO treatment depends on changes in paltelet counts, in addition
to the rise in Hb and pre-existing vascular disease.
Pre-dilution hemofiltration with on line generation of sterile infusate. J.
Petrie, V. Wilson, Y. Campbell, Renal Unit, Princess Alexandra
Hospital, Brisbane, Australia. Hemofiltration has a number of advan-
tages when compared to conventional hemodialysis. There is a marked
reduction in the incidence of hypotensive episodes during therapy. The
clearance of large molecules such as beta-2 microglobulin is increased.
It is claimed that patient survival is improved, particularly in the
elderly. The pre-dilutional mode, where the infusate is added to the
arterial side of the circuit, avoids excessive concentration of red cells
and protein and facilitates reuse. Urea clearance in the pre-dilutional
mode is equal to
Blood flow rate x infusate flow rate
Blood flow rate + infusate flow rate
At a blood flow rate of 400 mI/mm, approximately 50% more infusate is
required to produce a given clearance than with post-dilution. Conven-
tional hemofiltration is an extremely costly form of therapy. Because of
this the technique is used in less than 2% of dialysis patients world
wide. The Gambro MPS machine produces sterile infusate on line using
bacterial and pyrogen filters. We have used this machine in over 1500
hemofiltration treatments without encountering bacteremic or pyro-
genic complications. On line generation of sterile infusate along with the
re-use of hemofilters has produced substantial cost savings. These
savings have enabled us to treat 40% of our current in-center dialysis
population with this technique.
Predictors of outcome for arteriovenous fistulae. A.L. Buttimore, K.L.
Lynn, J.E. Wells, J.B. Morton. Departments of Surgery, and Commu-
nity Health and General Practice, Christchurch School of Medicine and
Department of Nephrology, Christchurch Hospital, Christchurch, New
Zealand. The outcome of arteriovenous fistulae was studied in patients
who began hemodialysis (HD) between 1 September 1979 and 31
August 1989. The first functioning fistula in 140 patients (85 men) aged
6 to 72 yr at the start of HD was analyzed retrospectively. The great
majority were constructed by, or under the direct supervision of, one
surgeon. All flstulae were in the upper limb; 122 forearm, 18 upper arm;
81 side-to-side anastomoses. The median time between formation and
first use was 40 days. Patients dialyzed for 6 to 10 hr 3 times weekly
using two needles. Follow-up was for <1 to 110 month and the survival
endpoint was the first fistula dysfunction requiring surgical interven-
tion. At follow-up 41 fistulae had functioned uneventfully, 30 were
functioning after at least one surgical procedure, 37 patients had been
transplanted, 27 were dead and 5 had other outcomes. Survival analysis
estimated fistula survival to be 82% at 1 year and 71% at 3 years.
Previous unsuccessful attempts at fistula formation (P = 0.0003) and
female sex (P = 0.008) were predictors of fistula dysfunction while age(P = 0.36), diagnosis (P 0.91), time from formation to use (P = 0.70)
and type of anastomosis (P = 0.12) were not. Survival of arteriovenous
fistulae is crucially dependent on the success of the first surgical
procedure. We suggest that this surgery be carried out by an experi-
enced surgeon with an interest in vascular access surgery.
Campylobacter peritonitis in CAPD. C. Wood, V. Fleming, N.M.
Thomson, R.C. Atkins, Departments of Nephrology and Microbiology,
Prince Henry s Hospital, Melbourne, Victoria 3004, Australia. Cam-
pylobacter are relatively common causes of acute diarrheal illness but
are rare causes of CAPD associated peritonitis, with only seven
previously-documented case reports. Over a fifteen month period there
have been seven episodes of peritonitis due to campylobacter species in
our CAPD population. Nine campylobacter have been isolated from
these seven episodes (Camp. jejuni: 6 Camp. coli: 2 Camp. landis: 1).
560 Abstracts
All patients (5 female: 2 male; age range 40 to 71 years) presented with
abdominal pain and cloudy dialysate. Diarrhea was a common finding at
presentation but the clinical severity was quite variable. In one patient
diarrhea preceded the episode of peritonitis by five days. The organism
was isolated from feces in all patients when tested during the acute
illness (N = 4). Two patients did not have fecal cultures performed, and
the remaining patient's cultures were sent two weeks after the acute
illness which were negative. Sensitivity profiles confirmed erythromy-
cm (9/9) and the aminoglycosides (8/9) as the most effective antibiotics,
but in three cases, clearing of the dialysate was obtained with an
antibiotic to which the organism demonstrated in vitro resistance
(piperacillin-2 vancomycin-l). Response to treatment was similar to
other forms of bacterial peritonitis (i.e. clearing of dialysate within Ito
4 days) following commencement of appropriate antibiotic therapy. We
conclude that campylobacter should be suspected as causing CAPD
peritonitis where diarrhea is noted either at presentation or within a few
days of onset of peritonitis; the most appropriate therapy is with
intraperitoneal aminoglycoside in combination with oral erythromycin.
Fecal cultures at presentation may be helpful.
Live donor renal grafts: A comparative analysis. P.J. Little, S. Barker,
A. MacDonald, J.P. McMullin, A.P.S. Disney, T.H. Mathew, Ibn
Al-Bitar Hospital, Baghdad, Iraq; ANZDA TA Registry, The Queen
Elizabeth Hospital, Woodville, SA 5011, Australia. During the period of
January 1983 to April 1989, 327 live-donor renal transplants (LDRT)
were reported to the ANZDATA Registry and 365 LDRT were per-
formed at the Lbn Al-Bitar Hospital, Baghdad. The overall results with
regard to kidney survival were almost identical, being 77.4% (ANZ-
DATA) and 77.7% (Ibn-Bitar) at 5 years. There were several differences
in donor selection and 5-year kidney survival.
Donor No.
ANZDATA
5 Year
Function No.
Ibn Al-Bitar
5 Year
Function
Sibling 130 78.8% 155 81.5%
Parent/child 164 77.4% 33 63.0%
Child/parent 22 59.8% 52 82.4%
Interspouse 3 — 28 71.0%a
Other relative 6 — 34 71.0%
Unrelated 2 — 63 8l.0%a
327 77.4% 365 77.7%
a 3 year kidney survival
Sixty-five percent of the ANZDATA patients received immunosuppres-
sion with cyclosporine and 44% received OKT3, ATG or ALG at some
stage post-operatively. Because of restricted supplies only 43% of the
Iraqi patients received cyclosporine and no OKT3, ATG or ALG was
used. The similarity in overall outcome despite marked differences in
the type of immunosuppression raise important questions, particularly
as the Australian series contained a vast majority of 1 haplotype or
better matches.
The effect of cyclosporine therapy on cadaver kidney transplant results
at a single center. l.R. Hardie, J. Petrie, R. Rigby, R. Strong, D. Wall,
S. Lynch, C. Hawley, P. Woodruff, J. Quinn, Renal Transplant Unit,
Princess Alexandra Hospital, Brisbane, Australia. From 1.1.81 to
31.10.89, when all cadaver kidney recipients were transfused and
HLA-DR typing was available, 646 grafts were performed in Brisbane:
546 first (CDKI), 93 second and 7 third grafts. In 344 CDKI, initial
therapy included cyclosporine (Cs); graft survival (GS) was 84 2% at
1 year, 81 3% at 2 year and 79 4% at 3 year. Azathioprine (Az) +
prednisolone (P) was initial therapy in 202 CDKI :1, 2 and 3 year GS was
75 3%, 65 4% and 59 4% (P < 0.05). Patient survival at 1, 2, 3,
4, and 5 years was:
Graft loss in years 2 and 3 averaged 2.5% per year after Cs induction
and 8% per year after Az+P. As Cs therapy included conversion to
Az+P at 3 months as well as long-term Cs, 46 converted electively were
studied: 36 had functioning grafts at 1 year, and only one graft was lost
during the next 2 years. Cancer was less frequent with Cs (14%) than
with Az+P (27%), both skin (12,5% vs. 21%) and visceral (1.4% vs.
5.5%) cancer being reduced. In both groups, 85% of those with cancer
had skin cancer only; two died from this (both Az+P), Total cancer
mortality was less with Cs (1.4% vs. 4%). Cs induction therapy has
reduced late graft loss, both with maintenance Cs therapy and with
conversion to Az+P at 3 months. Cs may also be associated with a
lower risk of cancer.
Synergistic inhibition of cytokine production, and prolongation of rat
renal allograft survival by anti-LL-2 receptor (IL-2R) monoclonal anti-
body (mAb) and cyclosporin (CsA). W. W. Hancock, H. Ueda, J.
Kupiec-Weglinski, N. Tilney, Department of Nephrology, Prince Hen-
ry's Hospital, Melbourne, Vic 3004, and Harvard Medical School,
Boston, Massachusetts 02115, USA. Only limited, largely in vitro-
based data exists as to how CsA or anti-IL-2R mAb suppress renal
allograft rejection (AR). We used mAbs and immunoperoxidase label-
ling to analyze intragraft production of cytokines/IL-2R critical to AR in
an LBN—Lewis rat renal allograft model. Rejection times, defined as
death from uremia, and intragraft cytokine production at 7 days in rats
subjected to no treatment (no Rx), or treatment with the anti-IL-2R
mAb, ART-18 (300 jig/kg/day, 10 day), CsA (15 or 0.75 mg/kg/day, 10
day) or ART-18 plus CsA (300 pg/kg/day plus 0,75 mg/kg/day, 10 d)
were:
Group
%IL-
2R+ LL-2 EFN-g TNF
Class
II
Survival
days
noRx 20±8% 3+ 2+ 3+ 3+ 10±4d
ART-18 10 6% 2+ 2+ 2+ 2+ 23 7 db
CsA 15 0 0% — 1+ >90db
CsA 0.75 18 4% 2+ 2+ 2+ 2+ 16 2 d
ART-18 & 4 3% 1+ >49&'
CsA 0.75
a p < b p < 0.001
Hence, anti-IL-2R therapy prolonged rat renal allograft survival, but
unlike in cardiac allografts, this effect was not explicable by IL-2R+
cell depletion; indeed modulation or IL-2R blockade appeared likely.
Like ART-18, but unlike full-dose CsA, low-dose CsA did not signifi-
cantly affect intragraft activation. However, ART-18 plus low-dose CsA
showed synergistic inhibition of IL-2R+ cells, IL-2, IFN-g, TNF and
Class II antigen induction, and prolonged survival. This synergy has
important clinical implications for the treatment of AR using newer
agents such as anti-IL-2R niAb, in conjunction with the frequently
nephrotoxic drug, CsA.
Tumor necrosis factor (TNF) in renal allograaft rejection. M. Fisher,
T.J. Neale, Department of Medicine, Wellington School of Medicine,
Wellington, New Zealand. TNF has been shown in vitro to enhance the
tissue expression of Class II NHC antigens in the presence of gamma-
interferon, while antibodies to TNF significantly inhibit the mixed
lymphocyte reaction, suggesting TNF is an important regulator of the
immune response in allograft rejection. To examine the role of TNF in
human graft rejection, serum TNF levels have been measured daily in
20 patients following renal transplantation (mean follow-up of 14 days).
A radioimmunoassay has been established where TNF in the serum
competes with a fixed amount of 1125 Hr TNF (radioiodinated by a
modified Lodogen method to a specific activity of I mCi/mmol), for the
binding sites on a rabbit polyclonal antibody. Assay sensitivity is 50 to
100 pg/mI with inter-assay coefficient of variance (c.v.) 7.8%, and
intra-assay c.v. 9.8% (N = 10). Peak serum TNF levels were elevated
(range 85 to 630 pg/mI) 24 to 48 hrs prior to clinical rejection in 10 of 11
episodes and on six occasions (range 129 to 300 pg/mI) in the absence of
clinical rejection; two of these occurring with viral infections. TNF was
also elevated to 319 pg/mI in one patient 2 hours after the first dose of
OKT3 at the time of 'flu-like' symptoms. TNF was not detected in the
sera of 40 patients with stable, functioning renal transplants. This data
with Cs: 92 1% 89 2% 83 3% 83 5% 83 9%
with Az + P: 96 1% 89 2% 85 2% 79 3% 70 4%
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may support a role for TNF in the early amplificatoin of the immune
response in renal allograft rejection.
Anemia and angiotensin converting enzyme (ACE) inhibition in renal
transplant recipients. P.C.B. Size/and, R.R. Bailey, K.L. Lynn, R.A.
Robson, Department of Nephrology, Christchurch Hospital, Christ-
church, New Zealand. The renin-angiotensin system has been shown to
have an effect on erythropoietin formation and hemoglobin concentra-
tion. Worsening of anemia has been reported in regular hemodialysis
patients treated with ACE inhibitors. We carried out a retrospective
study to see if a similar effect was evident in renal transplant patients.
Criteria for inclusion were stable transplant function, no change in
immunosuppressive therapy (prednisone 10 mg daily, azathioprine I to
2 mg/kg, cyclosporin A 2 to 5 mg/kg), no evidence of bleeding and a
sufficient number of hemoglobin measurements before and after starting
the ACE inhibitor. Fifteen patients fulfilled these criteria, of whom 14
received treatment with enalapril and 1 with captopril. Before treatment
commenced the mean hemoglobin concentration was 138.7 g/liter (SD
22.7). Within 4 months of ACE inhibitor therapy the mean hemoglobin
had fallen to 110.5 g/liter (23.2) (P < 0.001). Twelve of the 15 patients
had a significant fall in hemoglobin concentration. There was no evidence
of reticulocytosis or polychromasia to suggest hemolysis, and no parallel
change in leukocyte or platelet counts. This study has shown an associa-
tion between ACE inhibition and a reduction in hemoglobin concentration.
Prospective studies are needed to clarify the effect of inhibition of the
renin-angiotensin system on erythropoietin synthesis and release.
Twenty years experience of paediatric renal transplantation. I.R.
Hardie, J.R. Burke, B.L. Menzies, G.H. Hirst, Renal Transplant Unit,
Princess Alexandra Hospital and Department of Surgery, The Univer-
sity of Queensland, Australia. Between 1967 and October 1989, 42
children (32 girls, 10 boys) aged 2 to 15 years were treated by dialysis
and transplantation (Group 1: 1967-77 = 13; Group 2: 1978-89 = 29).
The main causes of renal failure were refiux nephropathy (40%)
glomerulonephritis (18%), FGS (12%) and medullary cystic disease
(12%). Bilateral nephrectomy was needed in 17 (Gpl = 10 [77%]; Gp2
= 7 [24%]), 13 for hypertension and 4 for recurrent infection. Fifty
grafts were done in 38 children (Gpl: 14 in 11; Gp2: 36 in 27); 4 were
from living related donors. Actuarial graft survival [GS] was 70%, 55%,
and 47% at 1, 5, and 10 years, with patient survival [PSI 97%, 89% and
78%. Results were better in Group 2: GS 75% at 1 year, 65% at 5 years
(op1 57%, 36%); PS 100% at 5 years, 80% at 10 years (Gpl 64% at 5 and
10 years). Nine deaths occurred (Gpl = 6 146%]; Gp2 = 3 [10%], 5 due
to hypertension (HT) causing left ventricular failure (4) and cerebral
hemorrhage (1). Only one child died with a functioning graft. HT also
caused significant morbidity in 25 others (60%). All children have
maintained normal schooling; 8 of 20 who have reached school leaving
age have gone on to tertiary studies. 90% have normal activity and 88%
are working or at school. A policy of early transplantation gives
excellent survival and rehabilitation of children with renal failure.
Adequate blood pressure control has reduced the mortality previously
associated with this complication.
